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ABSTRACT 
 
The relationship between alcohol consumption and traumatic brain injury (TBI) often 
focuses on alcohol consumption increasing the likelihood of incurring a TBI, rather than alcohol 
use outcomes after TBI. This focus is in part due to the large numbers of TBI patients visiting 
emergency rooms notable levels of alcohol in their blood. Additionally, increases in alcohol use 
disorders following TBI can be predicted by previous history of alcohol use. However, studies 
have also shown patients without a history of an alcohol use disorder can experience increases 
in problem drinking after single or multiple TBIs. Due to the diffuse impact of alcohol 
consumption and mild TBI on the brain, it is likely that an interaction exists between TBI 
outcomes and problematic alcohol use after TBI. To examine the impact of mild repetitive TBI 
(rmTBI) on voluntary alcohol consumption, male mice were subjected to four mild TBI or sham 
procedures over a two week period, then offered ethanol (20% v/v) for 2, 4, 6 or 8 weeks using 
the two-bottle choice, drinking in the dark paradigm. Following the drinking period, mice were 
sacrificed and brains were extracted to examine expression of the pro-inflammatory cytokine 
TNF-α, a possible shared mechanism of neuronal damage. An additional cohort of mice was 
subjected to the same rmTBI and voluntary ethanol paradigm and tested for cognitive and 
behavioral deficits following the set drinking period. Results indicate there is a temporary 
decrease in ethanol consumption following rmTBIs compared to Sham mice in this model. 
Results also suggest an attenuated expression of TNF-α in rmTBI, ethanol drinking groups 
compared to ethanol exposed mice after the Sham procedure. The outcomes of the cognitive 
and behavioral tasks suggest that ethanol consumption after rmTBI can cause transient 
cognitive dysfunction and increased novelty preference.   
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INTRODUCTION 
 
Traumatic Brain Injury 
Each year, in the United States, approximately 1.5-2.5 million Americans are 
hospitalized or seek medical treatment for a traumatic brain injury (TBI) (Faul M, Xu L, Wald 
MM, 2010; Niska, Bhuiya, & Xu, 2010). Although this is already a substantial number of people, 
there are also individuals who may not seek treatment at all making the overall prevalence of 
TBI grossly underestimated. In addition to civilian injuries, nearly 20% of soldiers are estimated 
to have experienced a TBI during deployment accounting for a significant additional number of 
injuries and they are at a much higher risk than the general public (Tanielian, T., Jaycox, 2008).  
Brain injuries vary in severity, and can have a significant impact on cognitive and motor 
function, sensation, and emotion (Ashman, Gordon, Cantor, & Hibbard, 2006; Thurman, 
Alverson, Dunn, Guerrero, & Sniezek, 1999). The majority of TBI cases are concussions, also 
called closed head injuries, which are classified as ‘mild’ (mTBI). This type of injury is identified 
by transient confusion, disorientation, or impaired consciousness; dysfunction of memory 
around the time of injury; and/or loss of consciousness lasting less than 30 minutes (National 
Center for Injury Prevention and Control, 2003). Despite the fact that up to 90% of TBIs are 
estimated to be mild (Holm, Cassidy, Carroll, & Borg, 2005; National Center for Injury 
Prevention and Control, 2003), currently, over 5 million Americans are living with a permanent 
TBI-related disability (Ashman et al., 2006; Thurman et al., 1999).  
One of the challenges of mTBI is that it can be difficult or impossible to observe tissue 
damage using standard brain imagining techniques such as magnetic resonance imaging (MRI) 
or computerized tomography (CT) as the physical damage is often limited to microstructures like 
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cell membranes and ion pumps (Delouche et al., 2015; Honce, Nyberg, Jones, & Nagae, 2016). 
Although it is difficult to visualize physical brain damage, long-term negative consequences of 
repetitive mTBIs have recently become increasingly apparent as more is learned about long-
term conditions that develop after TBI like post-concussion syndrome or chronic traumatic 
encephalopathy (CTE; Solomon & Zuckerman, 2015). In an extreme disorder like CTE, 
neurodegeneration, and development of tau protein tangles (Solomon & Zuckerman, 2015), are 
not the only possible long-term negative consequences. There is also an increased risk for 
excessive alcohol consumption following TBI which can lead to neurophysiological and 
behavioral consequences in civilian (J. D. Corrigan, 1995; Jorge et al., 2005) and military 
populations (Herrold  A. et al., 2014; Miller & Baktash, 2013). 
 
Alcohol Use  
 Alcohol use in America is widespread with more than half of people aged 12 and up (139 
million) consuming alcohol at least once in the past month.  Many of these people engage in 
problematic drinking behaviors such a binge drinking (60.9 million), defined as five or more 
drinks on one occasion, or heavy drinking (16.3 million), defined as five or more drinks on one 
occasion for five days in the past month (Center for Behavioral Health Statistics and Quality, 
2015).  In a subset of these populations, problem drinking can develop into an Alcohol Use 
Disorder (AUD) which is a mental health disorder characterized by the inability to stop drinking 
(“Substance-Related and Addictive Disorders,” 2013).   This disorder can be devastating to a 
person’s health, finances, and interpersonal relationships and can co-occur with other mental 
health disorders (Center for Behavioral Health Statistics and Quality, 2015). In addition, AUD is 
associated with long-term cognitive deficits including reductions in executive functions like 
decision making (Brevers et al., 2014; Le Berre et al., 2014), response inhibition (Naim-Feil, 
Fitzgerald, Bradshaw, Lubman, & Sheppard, 2014), attentional shifting (Goldman, Klisz, & 
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Williams, 1985; Rourke & Grant, 1999), reversal learning (Gladwin & Wiers, 2012; Trick, 
Kempton, Williams, & Duka, 2014), as well as memory impairment (Loeber et al., 2009) with 
some of these deficits extending into protracted abstinence.  
A number of animal models of voluntary ethanol consumption have been developed to 
study these and other alcohol related effects each with their own merits; for a review see Griffin, 
2014. The Drinking in the Dark (DID) paradigm is especially practical when modeling drinking 
behavior without the use of sucrose fading or ethanol vapor inhalation chambers. In this 
paradigm, mice are allowed to voluntarily consume ethanol and do so at levels considered to be 
mild intoxication or higher (80 mg/dl; Rhodes et al., 2007; Thiele, Crabbe, & Boehm, 2014; 
Thiele & Navarro, 2014) making it a highly translatable model for human drinking.  
 
TBI and Alcohol  
There has long been a relationship between alcohol consumption and TBI, but the 
causal relationship between TBIs and AUDs is difficult to discern. A large percentage of patients 
visiting emergency rooms with TBIs have notable levels of alcohol in their blood (Dikmen, 
Machamer, Donovan, Winn, & Temkin, 1995; Kraus, Morgenstern, Fife, Conroy, & Nourjah, 
1989; Weil, Corrigan, & Karelina, 2016). Likewise, increases in AUD following TBI can be 
predicted by previous history of alcohol use (Bombardier, Temkin, Machamer, & Dikmen, 2003; 
Dikmen et al., 1995; Horner et al., 2005; Rogers & Read, 2007). However, numerous studies 
have also shown patients without a history of AUD can experience increases in problem 
drinking after TBI (J. D. Corrigan, 1995; Hibbard, Uysal, Kepler, Bogdany, & Silver, 1998; 
Massagli et al., 2004; Silver, Kramer, Greenwald, & Weissman, 2001). Due to the global 
impacts of both alcohol consumption and TBI on the brain, it is likely that an interaction exists 
between TBI outcomes and problematic alcohol use rather than a simple, unidirectional causal 
association.  
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This series of three experiments further the existing literature by examining the effects of 
repetitive mTBI on voluntary ethanol consumption using mouse models. Then investigate the 
combined effects of rmTBI and voluntary ethanol consumption on neuroinflammation, cognition, 
and behavior.  The goal of the first experiment was to investigate the capacity of a repetitive 
mTBI model to induce excessive ethanol consumption post-injury as observed in portions of 
clinical populations. The model was also assessed for reliability by comparing ethanol 
consumption of multiple cohorts over the course of several weeks. The second experiment 
investigated the long-term consequences of ethanol consumption following repetitive mTBI on 
neuroinflammation in effort to understand possible shared mechanisms leading to neuronal 
damage. The final experiment explored the protracted effects of repetitive mTBI and ethanol 
consumption on neuronal recovery with a series of cognitive and behavioral performance 
measures.   
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EXPERIMENT 1: EFFECTS OF REPETITIVE TRAUMATIC BRAIN INJURY ON VOLUNTARY 
ETHANOL CONSUMPTION  
 
Alcohol use disorders and TBI independently represent major health problems with 17 
million people in the United States diagnosed with AUDs (Center for Behavioral Health Statistics 
and Quality, 2015) and over 1.5 million patients suffering a TBI annually (Faul M, Xu L, Wald 
MM, 2010; Niska et al., 2010). Research demonstrates that these mental health concerns are 
often comorbid. For example, incurring a TBI increases the likelihood of developing an AUD (J. 
D. Corrigan, 1995; Weil et al., 2016). On the other hand, the consumption of alcohol greatly 
increases the chances of sustaining a TBI and as many as 50% of TBI emergency room 
patients have levels of alcohol that surpass the legal limit for most states (Dikmen et al., 1995; 
Kraus et al., 1989).  
In clinical populations, mild TBI (mTBI) is more difficult to diagnose compared to 
moderate and severe TBIs and can even go untreated altogether because of the lack of visible 
symptoms. Nevertheless, mTBI can result in significant neurological symptoms such as 
headache, confusion, loss of consciousness, amnesia, chronic pain, and impaired cognitive 
function (Ashman et al., 2006; Gessel, Fields, Collins, Dick, & Comstock, 2007; Harmon et al., 
2013; National Center for Injury Prevention and Control, 2003). For most patients, symptoms 
appear to resolve spontaneously within 1-2 weeks, but data suggest there could be long-term 
consequences especially when the mTBIs are incurred repeatedly (Ashman et al., 2006; 
Harmon et al., 2013; Solomon & Zuckerman, 2015). Of these long-term consequences, post-
concussive syndrome and chronic traumatic encephalopathy tend to garner more attention from 
media sources; however, some evidence suggests that there can be a significant increase in the 
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risk of excessive drinking following mTBI which can also lead to troublesome outcomes in terms 
of health, interpersonal relationships, and psychological well-being (J. D. Corrigan, 1995).  
Increased alcohol use following TBI is a substantial concern as it can greatly impact an 
individual’s recovery from TBI and lead to greater risk of incurring additional TBIs (J. D. Corrigan 
et al., 2013). Military personnel are at an increased risk for TBI compared to the general 
population with nearly 20% of soldiers experiencing at least one TBI during their deployment. 
Similar to civilian populations, military personnel with or without a prior history of alcohol misuse 
can experience a greater risk of developing an AUD after incurring a TBI (Adams, Larson, 
Corrigan, Ritter, & Williams, 2013; Herrold  A. et al., 2014; Miller & Baktash, 2013; Tanielian, T., 
Jaycox, 2008). There is a paucity of research investigating the relationship between severity of 
injury or mechanism of injury (e.g. fall, motor vehicle accident) and increased drinking (Horner et 
al., 2005). Some patients with severe TBI decrease alcohol consumption post-injury possibly 
due to a reduction in ability or access and greater supervision (Bombardier et al., 2003; Dikmen 
et al., 1995). However, one interesting pattern in drinking behavior following TBI identifies a 
short period of reduced alcohol consumption immediately following the injury followed by 
escalations to problematic alcohol use (Ponsford, Whelan-Goodinson, & Bahar-Fuchs, 2007).  
An inherent issue when examining TBI patients using simple observation is the variable 
nature of the injuries. Brain area(s) affected, the severity of the injury, and whether the injury is 
local or diffuse can all lead to variation in symptoms and outcomes. Fortunately, these and other 
factors including past experience with drugs or alcohol and previous or current stressors can be 
controlled in the laboratory. Animal models of TBI make use of several mechanisms to induce 
TBI; these include an impactor piston directly to the brain or through the skull, fluid percussion, 
indirect/blast, and gravity assisted weight drop. Many experiments are designed to model 
severe trauma but more recently there have been modifications to mimic milder injuries. It is 
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important that models of mTBI avoid causing skull fractures, hemorrhaging, and major 
disruption of the vasculature as these would be considered more severe injuries.  
One such model utilizes the weight drop mechanism and has successfully generated 
mild to moderate TBIs modeled in mice. The variability in severity observed in this model is 
similar to the variability observed in medical settings and may be useful to test generalized 
treatment, but the variability can also limit the use of this model to understand mechanisms of 
mTBI specifically (Albert-Weißenberger, Várrallyay, Raslan, Kleinschnitz, & Sirén, 2012). A 
model of repetitive mTBI using the fluid percussion mechanism has also demonstrated 
exacerbated memory impairment, axonal damage, and astrocytic reactivity after a second mTBI 
was administered (Prins, Hales, Reger, Giza, & Hovda, 2011). In an attempt to study the causal 
relationship between repetitive mTBI and CTE, Petraglia and colleagues (2014) used an 
impactor model and induced 6 mTBI per day for 7 days. This model was successful in 
replicating a number of the behavioral and neurological symptoms characteristic of CTE, but 
with 42 cumulative mTBIs (Petraglia et al., 2014), it is more extreme than necessary to model 
repetitive mTBI for most populations. Another model of repetitive mTBI also uses the impactor 
piston mechanism to induce repetitive mild closed head injuries (rmCHI), but is more 
conservative with only 4 injuries over 2 weeks and has been able to replicate morphological and 
neurological outcomes of repetitive mTBI in humans (Yang et al., 2015). Similar to the 
observations of human mTBI, this model of rmCHI does not induce histological damage in mice 
that can be visualized using standard MRI, but instead some minor damage is observable when 
using diffusion imaging (Yang et al., 2015).  
 The literature using animal models to examine the relationship between mTBI and 
alcohol consumption is sparse and there are very few studies at this time investigating the effect 
of repetitive mTBI on alcohol drinking behaviors. One study using an impactor mechanism found 
increased drinking in mice after an acute TBI during adolescence (Weil, Karelina, Gaier, 
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Corrigan, & Corrigan, 2015). Another study used an acute blast model with rats, and found 
increases in drinking for injured animals compared to controls following initial access (Lim et al., 
2015). In this study, the researchers purposefully chose Sprague Dawley rats due to their 
naturally low preference for alcohol and the rats never drank to intoxication; therefore, it may be 
difficult to discern differences in drinking patterns with such low overall consumption. Unlike 
rats, mice drink to pharmacologically relevant blood ethanol concentrations (80 ml/dl) readily in 
the DID paradigm (Thiele & Navarro, 2014).  Consequently, this longitudinal experiment aims to 
investigate the effects of rmCHI on ethanol consumption over the course of several weeks using 
a well characterized model of repetitive mTBI (Yang et al., 2015) and a well-established mouse 
voluntary drinking model (Rhodes, Best, Belknap, Finn, & Crabbe, 2005; Thiele et al., 2014; 
Thiele & Navarro, 2014).  
 
Hypotheses 
Despite patients with TBI reporting an increased prevalence of alcohol consumption 
following their injury, there is sparse preclinical data investigating the impact of rmTBI on alcohol 
consumption patterns.  Therefore the aim of Experiment 1 was to establish the rmCHI model as 
an acceptable model to investigate the excessive ethanol consumption post-injury observed in 
clinical populations. It was expected that all mice (sham and rmTBI) would consume enough 
ethanol during the drinking periods each day to induce pharmacologically relevant blood ethanol 
concentrations (BECs, Rhodes et al., 2007; Thiele & Navarro, 2014). Average drinking levels 
are expected to be greater than 6 g/kg after the 4hr drinking period at the end of each week with 
corresponding BECs of approximately 80 mg/dl (Rhodes et al., 2007). It was probable that an 
initial period of reduced drinking would be observed in rmTBI mice, but because the induced 
mTBIs did not physically debilitate the mice, this effect on ethanol consumption was expected to 
be minimal compared to observations of humans after more severe TBI (Ponsford et al., 2007). 
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It was also hypothesized that mTBI mice would exhibit a greater preference for ethanol 
compared to the sham mice which could be attributed to a number of mechanisms including 
reduced frontal lobe inhibition or damage to the dopaminergic reward pathways which will be 
considered for exploration in future experiments (Crews et al., 2006; Jorge et al., 2005; Weil et 
al., 2016).  
 
Methods 
 
Subjects 
Ninety-six adult (8-12 weeks old) male C57BL/6J mice (Envigo Laboratories, 
Indianapolis, IN, USA) were used for a total of 12 mice per condition (Weil et al., 2015; Yang et 
al., 2015). Food and water were freely available throughout the duration of the experiment and 
all mice were maintained on a 12hr reverse light/dark cycle (6 pm/6 am) in a temperature- and 
humidity-controlled animal facility. Mice were transported to a separate room prior to rmTBI 
induction and all drinking measures occurred in the home cage. This experiment was conducted 
according to a protocol approved by the Institutional Animal Care and Use Committee of the 
University of South Florida, and was in accordance with the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals. 
 
Repetitive Mild Traumatic Brain Injury 
To model the repetitive mTBI observed in humans, a conservative, but a validated model 
of rmCHI was used (Yang et al., 2015). Mice were anesthetized with 4% isoflurane and 
maintained at 2–3% isoflurane throughout the procedure. Using a PSI TBI-0310 Impactor 
(Precision systems and instrumentation, LLC, USA) fitted with a custom silicon rubber tip (1 cm 
in thickness, 9 mm in diameter), four brain traumas were induced on the center point of the 
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sagittal suture with 72hrs of recovery time between impacts. Each impact was made at 4.0 m/s, 
3.8 mm compression depth and a 200ms dwell time (compression duration). Sham animals 
were anesthetized and placed in the impactor for a similar duration, but did not experience the 
impact. Mice were returned to home cages immediately after the injury procedure where they 
had access to ad libitum water and food and were monitored for health. After the four injuries or 
sham procedures, the animals would have an additional two days of recovery prior to ethanol 
exposure. 
 
Voluntary Ethanol Consumption 
Voluntary ethanol consumption was determined using a well-established DID paradigm 
(Rhodes et al., 2005; Thiele et al., 2014; Thiele & Navarro, 2014). Ethanol solutions were made 
daily by diluting a 95% (v/v) ethanol with tap water to a 20% (v/v) concentration. Solutions were 
presented using sipper tubes featuring a ball bearing nozzle (Thiele et al., 2014). Ethanol was 
available 3hrs after the dark cycle had started and remained available for 2hrs on Days 1-3 and 
4hrs on Day 4, and the mice remained abstinent on Days 5-7; see Figure 1 for illustration of the 
timeline.  
 
 
Figure 1.  Experiment 1 Timeline 
Partial timeline for experiment 1 depicting rmTBI schedule and one week of ethanol (EtOH) 
consumption. Ethanol consumption continued for 2, 4, 6, or 8 weeks.  
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Separate cohorts were able to consume ethanol for 2, 4, 6, or 8 weeks to measure 
changes in drinking patterns longitudinally. During the intake period, mice were presented with a 
sipper filled with 20% ethanol solution and regular drinking water. Prior to placing the sippers on 
the cages and at the conclusion of the drinking period, the total volume of each solution (ml) 
consumed was recorded. The position of the bottles alternated daily to negate any side 
preferences. Drinking was voluntary as water was available at all times during the experiments. 
The amount of water and ethanol were recorded daily and blood samples were taken once per 
week on immediately following the Day 4 drinking session via a standard submandibular bleed 
procedure. After the final drinking session, the mice were given a lethal dose of isoflurane, so 
that the brains could be cleared of blood via transcardial perfusion with phosphate buffered 
solution and extracted for use in additional experiments. 
The two-bottle choice variant of the DID paradigm was chosen as it allows for ethanol 
preference to be determined and mice maintain similar amounts of voluntary ethanol 
consumption (g/kg), though it is likely that the results produced reflect a slight decrease in blood 
ethanol concentrations (BEC) compared to the single bottle option (Rhodes et al., 2007). Still, 
researchers using this model have been able to demonstrate pharmacologically meaningful 
BECs in C57BL/6J non-dependent mice and even binge-like drinking levels of more than 80 mg 
of ethanol/dl of blood (Thiele et al., 2014).  
Blood samples were centrifuged (1,500 x g) following collection and the ethanol 
concentration measured using an Analox Instrument analyzer (Lunenburg, MA, USA). Plasma 
samples were analyzed immediately or stored at -20 degrees Celsius until analyzed. 
 
Analyses 
All analyses were conducted with SPSS 25.0 (IBM). A p-value less than 0.05 was set to 
evaluate significance unless otherwise indicated. Outliers were identified and removed following 
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Tukey’s method creating boxplots and removing data points falling outside the ±1.5 interquartile 
range. Results of analyses that are not mentioned specifically are non-significant. 
In order to test the prediction of increased ethanol consumption in rmTBI mice compared 
with sham controls each week of the drinking period, two-way mixed ANOVAs, Procedure 
(rmTBI vs sham) x Week were conducted comparing the average daily ethanol consumption 
(g/kg) over the set drinking time (2, 4, 6 or 8 weeks of drinking) for each cohort. To better 
understand any significant changes in ethanol consumption, two-way mixed ANOVAs were run 
to assess decreases in total fluid (water and ethanol) consumed. In order to look at variance in 
consumption within weeks while accounting for possible bottle placement preference, 
consumption patterns (g/kg) for Days 1 & 2 and Days 3 & 4 were analyzed using mixed ANOVA 
to compare rmTBI, Week, and Day. These analyses were repeated for ethanol preference. 
Ethanol (g) intake was calculated by multiplying the volume (ml) of ethanol consumed by the 
specific density of 20% v/v concentration of ethanol by 1000 and then dividing by the mouse’s 
weight in grams for a g/kg measure.  Ethanol preference was calculated by dividing total (ml) of 
EtOH by the total amount of fluid (water and ethanol) consumed. Any significant ANOVA main 
effects or interactions were followed with Bonferroni adjusted pairwise comparisons to 
determine which simple effects were statistically significant.   
 
Results 
 
2 Week Cohort 
A 2 x 2 Procedure (rmTBI, Sham) x Week (1, 2) mixed ANOVA was conducted to 
determine if there were any differences in average ethanol consumption (g/kg) and an additional 
analysis was conducted to examine ethanol preference in the 2 Week cohort. As shown in 
Figure 2, Panel A, results indicated no significant differences in ethanol drinking related to 
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rmTBI or between Weeks 1 and 2. However, mice showed a decreased ethanol preference 
related to Procedure, F(1, 34) = 5.416, p < .05. As illustrated in Figure 2, Panel B, Bonferroni 
pairwise comparison showed a decrease in the rmTBI group (M = 76.7%) compared to Sham 
(M = 86.3%). Mice also showed an increase in preference from Week 1 (M = 75.5%) to Week 2 
(M = 87.5%), F(1, 34) = 8.487, p < .05.  
A 2 x 2 x 2 Procedure (rmTBI, Sham) x Day (Days 1 & 2, Days 3 & 4) x Week (1, 2) 
mixed ANOVA was conducted to examine changes in daily consumption patterns and an 
additional analysis was used to examine ethanol preference patterns. As shown in Figure 2, 
Panel C, results indicated that mice drank more ethanol on Days 3 & 4 (M = 1.47g/kg) 
compared to Days 1 & 2 (M = 1.17g/kg), F(1, 40) = 4.670, p < .05.  Similarly, mice showed a 
significant increase in ethanol preference during Days 3 & 4 (M = 85.3%) compared to Days 1 & 
2 (M = 77.7%), F(1, 40) 4.608, p < .05 as shown Figure 2, Panel D. 
In summary, there is insufficient evidence to support the hypothesis of increased ethanol 
intake following rmTBI, in fact, the data suggest a slight decrease in ethanol preference due to 
rmTBI despite an increase in ethanol preference from Week 1 to Week 2.  Daily patterns of 
ethanol intake and preference support increased drinking and preference of ethanol on Days 3 
& 4 of the four-day drinking paradigm. The variation observed between Days 1 & 2 and Days 3 
& 4 imply that day to day voluntary drinking has not yet reached a stable consumption pattern 
which can sometimes take a few weeks. 
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Figure 2. Ethanol consumption and preference in Week 2 Cohort. 
A) Average daily voluntary ethanol consumption and B) average daily ethanol preference C) 
ethanol intake by Days 1 & 2 and Days 3 & 4 D) ethanol preference by Days 1 & 2 and Days 
3 & 4. 
 
4 Week Cohort  
A 2 x 4 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4) mixed ANOVA was conducted to 
determine if there were any differences in average ethanol consumption (g/kg) in the 4 Week 
cohort. As shown in Figure 3, Panel A, results indicated significant main effects of Week, F(3, 
81) = 6.71, p < .05 and Procedure, F(1, 81) = 30.570, p < .05. These effects were qualified by a 
significant Procedure x Week interaction, F(3, 81) = 4.060, p < .05. Corrected pairwise 
comparisons specifically showed rmTBI mice consumed less ethanol than Sham mice in Week 
2 (Sham, M = 1.49g/kg; rmTBI, M = 0.76g/kg), Week 3 (Sham, M = 2.19g/kg; TBI, M = 
1.15g/kg), and Week 4 (Sham, M = 1.78g/kg; rmTBI, M =1.04g/kg). The decrease in ethanol 
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consumption observed in Week 2 appears to be mediated by an overall decrease in fluid intake 
as revealed by two-way ANOVA main effect of Week, F(3, 79) = 9.926, p < .05 as well as main 
effect of Procedure, F(1, 79) = 23.639, p < .05. Specifically, there was a decreased total fluid 
consumption in Week 2 (M = .320) compared to Week 1 (M = .536ml), Week 3 (M = .489ml), 
and Week 4 (M = .500) and decreased fluid intake (ml) in rmTBI mice (M = .390) compared to 
Sham mice (M = .533). A 2 x 2 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4) mixed ANOVA was 
conducted to determine if there were any differences in average ethanol preference in the 4 
Week cohort. As shown in Figure 3, Panel B, results indicated a significant decrease in ethanol 
preference across Week F(3, 63) = 4.597, p < .05, as well as, a significant decrease in ethanol 
consumption due to Procedure F(1, 63) = 4.249, p < .05. Bonferroni pairwise comparison 
indicated the decrease in ethanol preference across weeks was related to mice drinking less in 
Week 4 (M = 73.7%) compared to Week 2 (M = 86.3%) and Week 3 (M = 86.3%). Across all 
four weeks, Sham mice showed higher ethanol preference (M = 85.6%) compared to mice 
exposed to rmTBI (M = 79.4%).  
A 2 x 2 x 4 Procedure (rmTBI, Sham) x Day (Days 1 & 2, Days 3 & 4) x Week (1, 2, 3, 4) 
mixed ANOVA was conducted to examine changes in daily ethanol consumption patterns 
between Days 1 & 2 and Days 3 & 4 in the 4 Week cohort. As shown in Figure 3, Panel C, mice 
drank more on Days 3 & 4 (M = 1.70g/kg) compared to Days 1 & 2 (M = 1.31g/kg), F(1, 81) = 
25.02, p < .05. A 2 x 2 x 2 Procedure (rmTBI, Sham) x Day (Days 1 & 2, Days 3 & 4) x Week (1, 
2, 3, 4) mixed ANOVA was used to examine changes in daily ethanol preference patterns 
between Days 1 & 2 and Days 3 & 4. As shown in Figure 3, Panel D, results indicated a 
significant Day x Week interaction, F(3, 63) = 4.878, p < .05. Bonferroni corrected pairwise 
comparisons showed mice displayed an increase in preference from Days 1 & 2 (M = 80.4%) to 
Days 3 & 4 (M = 92.0%) during Week 2, but in Week 3, mice showed a decrease in preference 
from Days 1 & 2 (M = 91.8%) to Days 3 & 4 (M = 80.8%).  
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In summary, results indicate a rmTBI-dependent decrease in consumption of ethanol 
during Week 3 and Week 4 accompanied by a decrease in ethanol preference in Week 4. The 
day to day consumption patterns still indicated lack of stable intake which is corroborated by the 
observed variation of ethanol preference in the daily preference patterns. 
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Figure 3. Ethanol consumption and preference in Week 4 Cohort. 
A) Average daily voluntary ethanol consumption and B) average daily ethanol preference C) 
ethanol intake by Days 1 & 2 and Days 3 & 4 D) ethanol preference by Days 1 & 2 and Days 
3 & 4. 
 
6 Week Cohort 
A 2 x 6 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4, 5, 6) mixed ANOVA was used to 
determine if any differences in average ethanol consumption (g/kg) or ethanol preference were 
present in the 6 Week cohort. As shown in Figure 4, Panel A, results of the ethanol intake 
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comparison revealed a significant main effect for Week, F(5, 124) = 5.659, p < .05. Bonferroni 
adjusted pairwise comparisons showed mice drank more ethanol in Week 4 (M = 3.15g/kg) 
compared to Week 2 (M = 2.30g/kg), Week 3 (M = 2.25g/kg), Week 5 (M = 2.40g/kg), and Week 
6 (M = 2.10g/kg). As shown in Figure 4, Panel B, there were no differences in ethanol 
preference due to rmTBI or across Weeks in the 6 Week cohort. 
 
A  
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Figure 4. Average ethanol consumption and preference in Week 6 Cohort. 
A) Average daily voluntary ethanol consumption and B) average daily ethanol preference. 
 
A 2 x 2 x 6 Procedure (rmTBI, Sham) x Day (Days 1 & 2, Days 3 & 4) x Week (1, 2, 3, 4, 
5, 6) mixed ANOVA was conducted to examine changes in daily consumption patterns and an 
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additional analysis was conducted to examine differences in ethanol preference patterns 
between Days 1 & 2 and Days 3 & 4 in the 6 Week cohort. As shown in Figure 5, Panel A, 
results a significant main effect of Day, F(1, 124) = 26.596; however, this effect was qualified by 
a significant Day x Week interaction, F(5, 124) = 5.626, p < .05. Mice drank more in Days 3 & 4 
(M = 3.02 g/kg) compared to Days 1 & 2 (M = 2.08g/kg) in Week 1. Similarly, in Week 3, mice 
drank more during Days 3 & 4 (M = 2.61 g/kg) compared to Days 1 & 2 (M = 2.08g/kg). As 
shown in Figure 5, Panel B, there was also a significant Day x Week interaction, F(5, 123) = 
7.748, p < .05. During Week 1, mice showed an increased ethanol preference from Days 1 & 2 
(M = 66.7%) to Days 3 & 4 (M = 86.7%) while during Week 3, mice displayed a decreased 
preference from Days 1 & 2 (M = 85.2%) to Days 3 & 4 (M = 75.2%).  
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Figure 5. Days 1 & 2 and Days 3 & 4 Ethanol consumption and preference in Week 6 Cohort. 
A) Ethanol intake by Days 1 & 2 and Days 3 & 4 B) ethanol preference by Days 1 & 2 and 
Days 3 & 4. 
 
In summary, an overall increase in ethanol consumption was observed in Week 4 of the 
6 Week cohort for both rmTBI and Sham conditions. However, this change was not 
accompanied by any changes in average ethanol preference. The observations of daily ethanol 
intake and preference suggest drinking has stabilized towards the later weeks of the drinking 
period as differences in Day 1 & 2 vs Day 3 & 4 are no longer evident after Week 3.  
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8 Week Cohort 
A 2 x 8 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4, 5, 6, 7, 8) mixed ANOVA was used 
to determine if any differences in average ethanol consumption (g/kg) were present in the 8 
Week cohort. As shown in Figure 6, Panel A, results revealed a significant main effect of Week 
F(7, 163) = 4.032, p < .05, as well as a significant main effect of Procedure F(1, 163) = 72.826, 
p < .05. Bonferroni pairwise comparison showed mice drank more ethanol in Week 4 (M = 
2.81g/kg) compared to Week 7 (M = 2.05g/kg) and Week 8 (M = 2.10g/kg). Across the 8 Week 
drinking period, mice also showed a decrease in ethanol consumption due to rmTBI (M = 
2.02g/kg) compared to Sham (M = 2.71g/kg). A 2 x 6 Procedure (rmTBI, Sham) x Week (1, 2, 3, 
4, 5, 6, 7, 8) mixed ANOVA was used to determine if the decreased ethanol consumption was 
related to decreased total fluid intake. Results indicated main effects of Week, F(7, 163) = 
4.850, p < .05 and Procedure, F(1, 163) 34.381, p < .05. Corrected pairwise comparisons 
showed mice drank less total fluid during Week 7 (M = .553ml), and Week 8 (M = .570ml) 
compared to Week 1 (M = .759), and drank less after rmTBI (M = .588ml) when compared with 
Sham (M = .708ml) across weeks. However, these changes in total fluid intake do not fully 
account for the specific decrease in ethanol consumption (g/kg) previously described. A 2 x 8 
Procedure (rmTBI, Sham) x Week (1, 2, 3, 4, 5, 6, 7, 8) mixed ANOVA was used to examine 
differences in average ethanol preference. As shown in Figure 6, Panel B, results revealed a 
significant interaction of Week and Procedure F(7, 161) = 2.403, p < .05. Corrected pairwise 
comparisons indicated that mice in the rmTBI group (M = 69.1%) displayed a decreased ethanol 
preference during Week 5 compared to Sham (M = 90.4%). 
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Figure 6. Average ethanol consumption and preference in Week 8 Cohort. 
A) Average daily voluntary ethanol consumption and B) average daily ethanol preference. 
 
A 2 x 2 x 8 Procedure (rmTBI, Sham) x Day (Days 1 & 2, Days 3 & 4) x Week (1, 2, 3, 4, 
5, 6, 7, 8) mixed ANOVA was conducted to examine changes in daily consumption patterns 
between Days 1 & 2 and Days 3 & 4 in the 8 Week cohort. As shown in Figure 7, Panel A, 
results indicated a significant Day x Week interaction, F(7, 163) = 3.584, p < .05. Bonferroni 
adjusted pairwise comparisons showed mice drank more on Days 3 & 4 (M = 2.67g/kg) than on 
day Days 1 & 2 (M = 2.07g/kg) in Week 1. Likewise, in Week 2, mice drank more on Days 3 & 4 
(M = 2.57g/kg) compared to Days 1 & 2 (M = 2.18g/kg), and again in Week 3, mice showed 
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elevated intake on Days 3 & 4 (M = 2.71g/kg) compared to Days 1 & 2 (M = 2.07g/kg). After 
week 4, drinking levels stabilized across days.  A 2 x 2 x 8 Procedure (rmTBI, Sham) x Day 
(Days 1 & 2, Days 3 & 4) x Week (1, 2, 3, 4, 5, 6, 7, 8) mixed ANOVA was conducted to 
determined differences in ethanol preference patterns between Days 1 & 2 and Days 3 & 4 in 
the 8 Week cohort. As shown in Figure 7, Panel B, results indicated a significant Day x Week x 
Procedure interaction, F(7, 161) = 3.734, p < .05. Specifically, in Week 1, rmTBI mice displayed 
a decrease in ethanol preference from Days 1 & 2 (M = 85.4%) to Days 3 & 4 (M = 57.0%). 
Similarly, in Week 3, rmTBI mice showed a decrease of ethanol preference from Days 1 & 2 (M 
= 84.8%) to Days 3 & 4 (M = 72.3%).  
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Figure 7. Days 1 & 2 and Days 3 & 4 Ethanol consumption and preference in Week 8 Cohort. 
A) Ethanol intake by Days 1 & 2 and Days 3 & 4 B) ethanol preference by Days 1 & 2 and 
Days 3 & 4. 
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In summary, an overall increase in ethanol consumption was again observed in Week 4 
for both rmTBI and Sham conditions. However, there was also a rmTBI-dependent decrease in 
consumption most notably in Weeks 3, 4, and 5 of the 8 Week cohort. Average ethanol 
preference was generally observed to be similar between groups with the exception of a notable 
rmTBI decrease in preference during Week 5. The observations of daily ethanol intake and 
preference support the previous observation in the 6 Week cohort of stabilized ethanol drinking 
and preference after Week 3. 
 
Blood Ethanol Concentration and Day 4 Ethanol Consumption 
Blood samples were taken after the 4hr drinking session on Day 4 each week of the 
experiment for all cohorts. A simple linear regression was used to investigate the relationship 
between the total volume of ethanol consumed (g/kg) on Day 4 with BEC (mg/dl). As expected, 
the amount of ethanol consumed (g/kg) significantly predicted BEC, F(1, 444) = 250.20, p < .05 
showing a moderate relationship, r2 = .36; results are illustrated in Figure 8. This observation 
provides support of the DID drinking paradigm applied following rmTBI as ethanol intake (g/kg) 
values yielded proportional BECs values that would be considered intoxicating in humans (J. S. 
Rhodes et al., 2007). Group means of BEC and Day 4 ethanol consumption (g/kg) are included 
below in Table 1.  
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Figure 8. Blood ethanol levels as a factor of EtOH on Day 4 across cohorts.  
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Table 1. Blood Ethanol Concentration and Ethanol Consumption by Group and Week 
Procedure Week  N BEC(mg/dl)  SEM  N 4hr Intake g/kg  SEM 
Sham  1  12 49.59 ± 13.94  12 4.04 ± 0.54 
 2  12 32.70 ± 10.40  12 3.32 ± 0.40 
TBI 1  12 22.28 ± 5.00  12 2.87 ± 0.43 
 2  12 22.16 ± 6.12  12 2.78 ± 0.30 
            
Sham 1  12 55.30 ± 11.95  12 4.29 ± 0.28 
 2  12 39.53 ± 9.98  12 4.28 ± 0.40 
 3  10 33.26 ± 16.88  10 4.36 ± 0.44 
 4  11 20.53 ± 8.53  11 4.30 ± 0.40 
TBI 1  11 61.18 ± 12.02  11 3.59 ± 0.46 
 2  12 33.27 ± 11.78  12 3.23 ± 0.77 
 3  11 7.67 ± 1.53  11 3.00 ± 0.57 
 4  12 7.64 ± 2.74  12 2.34 ± 0.43 
            
Sham 1  11 84.87 ± 11.37  11 7.01 ± 0.47 
 2  11 43.35 ± 14.67  11 5.70 ± 0.63 
 3  11 39.74 ± 14.90  11 6.00 ± 0.55 
 4  12 57.70 ± 17.51  12 6.42 ± 0.46 
 5  12 47.29 ± 20.08  12 5.53 ± 0.44 
 6  12 19.16 ± 9.84  12 4.12 ± 0.44 
TBI 1  5 113.50 ± 31.58  5 6.56 ± 0.71 
 2  8 62.79 ± 20.64  8 5.60 ± 0.55 
 3  11 56.48 ± 14.62  11 5.88 ± 0.64 
 4  9 68.97 ± 18.85  9 6.15 ± 0.62 
 5  9 52.51 ± 12.40  9 4.46 ± 0.32 
 6  12 15.38 ± 6.76  12 3.85 ± 0.28 
            
Sham 1  11 96.91 ± 14.13  11 7.03 ± 0.42 
 2  12 59.43 ± 10.85  12 6.78 ± 0.50 
 3  12 56.60 ± 13.69  12 6.71 ± 0.35 
 4  11 44.25 ± 12.51  11 6.05 ± 0.31 
 5  12 71.74 ± 15.90  12 5.52 ± 0.36 
 6  11 20.39 ± 7.84  11 4.50 ± 0.31 
 7  12 46.50 ± 11.76  12 4.87 ± 0.23 
 8  12 19.55 ± 6.24  12 4.01 ± 0.22 
TBI 1  13 81.40 ± 17.16  13 5.97 ± 0.48 
 2  11 42.36 ± 11.39  11 4.91 ± 0.58 
 3  11 22.00 ± 7.35  11 4.54 ± 0.34 
 4  10 23.06 ± 9.27  10 4.91 ± 0.49 
 5  12 22.47 ± 6.65  12 4.56 ± 0.49 
 6  12 15.33 ± 5.85  12 4.63 ± 0.54 
 7  11 20.87 ± 11.42  11 4.31 ± 0.58 
 8  11 18.55 ± 7.34  11 3.85 ± 0.42 
BEC, blood ethanol concentration. 
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Discussion 
 The DID two-bottle choice paradigm was successfully employed as data demonstrated 
that all groups consistently consumed ethanol volumes per body weight that produced 
physiologically relevant BEC levels. The drinking levels are corroborated by the BEC collected 
on Day 4 each week. Both ethanol intake levels and BEC levels are consistent with what other 
groups using this drinking paradigm have previously published (Crabbe et al., 2009; Lee, 
Coehlo, Solton, & Szumlinski, 2017; Marianno, Abrahao, & Camarini, 2017; J. S. Rhodes et al., 
2007; Justin S. Rhodes et al., 2005). Daily drinking stabilized after 4 weeks of ethanol exposure, 
with few groups exhibiting a change in ethanol intake between days 1&2 and days 3&4 from 
week 5 onward. The preference data showed a consistent preference for ethanol over water 
across 2, 4, 6, and 8 Week drinking cohorts. While there was initially more variability in daily 
preference scores, this also stabilized over time.  
Whereas the DID paradigm was effective in producing reliable drinking data at similar 
levels observed by other researchers (Crabbe et al., 2009; Lee, Coehlo, Solton, & Szumlinski, 
2017; Marianno, Abrahao, & Camarini, 2017; J. S. Rhodes et al., 2007; Justin S. Rhodes et al., 
2005), there was no evidence for elevated voluntary ethanol consumption or an escalated 
drinking pattern following this model of repetitive mTBI when compared to sham. In fact, for the 
4 and 8 week cohorts, rmTBI mice consumed less ethanol than Sham mice. In the 4 week 
cohort, the decrease in g/kg volumes were accompanied by decreased ethanol preference; 
however, this effect on preference was not repeated in the 8 week cohort. While escalated 
drinking was not present following TBI, a temporary decrease in voluntary consumption is 
similar to what is reported in some clinical populations following injury prior to possible 
escalations in drinking (J. Corrigan, Rust, & Lamb-Hart, 1995).   
The decreases in ethanol consumption observed in this study differ from other animal 
models of TBI that observed a bimodal change in ethanol consumption producing high low 
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ethanol drinkers following blast induced TBI compared to sham (Mayeux, Teng, Katz, Gilpin, & 
Molina, 2015). However, Mayeux and colleagues (2015) used an outbred rat model which 
differs considerably from the inbred mouse strain, C57BL/6, used in this study. The difference in 
outcomes highlights two important choices of methods. First, Sprague Dawley rats are generally 
considered a low ethanol preferring model, whereas the C57BL/6J mice normally drink 
moderately high volumes of ethanol without training or forced consumption. Additionally, genetic 
variability may play an important role as only approximately 20% of patients in clinical 
populations are reported to excessively drink following TBI without previous history of AUD   
(Bombardier et al., 2003; Dikmen et al., 1995; Horner et al., 2005). The C57BL/6J mouse strain 
is genetically homogenous without the genetic variability that may contribute to the bimodal 
distribution of ethanol consumption producing high and low drinkers after TBI. Another study 
looking at an outbred mouse strain, Swiss Webster, found increased ethanol consumption in 
adulthood after a single TBI incurred during adolescence in female mice (Weil et al., 2015). It is 
possible that increased consumption may be seen because of genetic markers present in the 
outbred strain not found in the inbred C57BL/6J mice. - 
 
Conclusions  
Clinical populations sometimes show a decrease in drinking for up to two months post-
injury, and then others report increases in problem or excessive drinking without previous 
history following TBI (Bombardier et al., 2003; Dikmen et al., 1995; Horner et al., 2005). It is 
possible that our C57BL/6J mouse model does not have a natural genetic variant that 
contributes to excessive drinking observed in a portion of the population following TBI. However, 
while the proposed hypothesis was not supported, because genes are commonly manipulated 
in C57Bl/6J mice using knock-out, knock-in, and transgenic models, C57Bl/6J mice may serve 
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as an excellent tool to explore the influences of specific genes on the vulnerability to rmTBI-
induced increases in ethanol intake.  
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EXPERIMENT 2: EFFECT OF REPETITIVE MILD TRAUMATIC BRAIN INJURY AND 
VOLUNTARY DRINKING ON NEURONAL CYTOKINES 
 
Over 1.5 million patients suffer a traumatic brain injury (TBI) annually (Faul M, Xu L, 
Wald MM, 2010; Niska et al., 2010), TBI’s represent a major health problem in America. In fact, 
TBI represents a leading cause of disability and death for otherwise healthy adolescents and 
adults (Holm et al., 2005; National Center for Injury Prevention and Control, 2003), and is 
estimated to have an economic impact of nearly $40 billion each year for those requiring 
hospitalization (Silver et al., 2001). Remarkably, the majority of TBI cases are closed head 
injuries (i.e. concussions) that are classified as ‘mild’ (mTBI) and often do not require 
hospitalization. Such injuries are not generally visualized standard MRI and CT scans; however, 
advanced techniques such as functional (fMRI) and diffusion tensor imaging (DTI) have recently 
had greater success identifying damage (Delouche et al., 2015; Honce et al., 2016). Typically, 
mTBIs are identified by reported symptoms such as transient confusion, disorientation, or 
impaired consciousness; dysfunction of memory around the time of injury; and/or loss of 
consciousness lasting less than 30 minutes (National Center for Injury Prevention and Control, 
2003).  
 The physical tissue damage that occurs from a TBI is referred to as the primary injury or 
phase; this is followed by a number of secondary mechanisms that can also have deleterious 
consequences. These delayed effects can occur in the minutes and hours following an injury or 
after weeks or months after the physical trauma (Morganti-Kossmann et al., 2005; Schmidt, 
Heyde, Ertel, & Stahel, 2005). Inflammatory responses are among the secondary effects that 
have received much attention in hope of developing new treatments. Neuroinflammation is the 
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result of a number of mechanisms including the upregulation of various pro-inflammatory 
cytokines and chemokines (Ghirnikar, Lee, & Eng, 1998; Ziebell & Morganti-Kossmann, 2010). 
Ghirnikar and colleagues (1998) review early studies of neurological insult that describe the 
involvement of several cytokines and chemokines including interleukin-1 (IL-1), IL-6, IL-
8/macrophage inflammatory protein-2 in the rodent (MIP-2), IL-10, tumor necrotic factor (TNF-
α), Fas ligand (FasL), and monocyte chemoattractant protein (MCP-1). Neural cytokines and 
chemokines are involved with immune responses such as the regulation and migration of 
leukocytes, but they are also known to influence neuronal growth, communication, repair and 
survival (Ziebell & Morganti-Kossmann, 2010). While some of these molecules appear to have 
very clear neurotoxic effects and others appear to be neuroprotective, it has also been observed 
that the combined neuroinflammatory response is acutely harmful, but beneficial in the long 
term recovery from TBI (Finnie, 2013; Ziebell & Morganti-Kossmann, 2010). For example, IL-1 
and TNF-α are both considered neurotoxic based on their ability to exacerbate TBI and extend 
recovery times, and they can even work together to initiate inflammatory processes, disrupt the 
BBB, and recruit leukocytes (Chao, Hu, Ehrlich, & Peterson, 1995). Alternatively, IL-6 and IL-10 
are generally considered neuroprotective as evidence suggests that IL-6 can reduce apoptotic 
cell death and promote neuroregenerative factors, and IL-10 can reduce TNF-α induced 
inflammation (Kremlev & Palmer, 2005; Penkowa et al., 2003). IL-6 and IL-1 have also been 
shown to be significantly upregulated in patients with the most severe and even fatal TBI as 
presumably they are recruited to sites of injury to mediate tissue damage (Ferreira et al., 2014; 
Schneider Soares et al., 2012). Finally, the chemokines, IL-8/MIP-2 and MCP-1 are implicated 
in the recruitment of leukocytes contributing to neuroinflammation; however, IL-8 is also able to 
stimulate the production of nerve growth factor and therefore may also possess neurotropic 
benefits (Whalen et al., 2000; Xu et al., 2004).  
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 Alcohol is a well-known neurotoxic substance causing predictable neurodegeneration 
especially following chronic, heavy and binge use, and a number of mechanisms for these 
neurodegenerative effects have been examined including neuroinflammatory processes 
(Collins, Corso, & Neafsey, 1996; Crews, 1999; Crews et al., 2006; Obernier, Bouldin, & Crews, 
2002; Schmued & Hopkins, 2000). While neuroinflammation is only one of many ways alcohol 
can be detrimental to brain health, research demonstrating increased levels of cytokines in 
human alcoholics’ brains postmortem corroborate this hypothesis (He & Crews, 2008). Ethanol 
can disrupt the immune response by decreasing levels of systemic cytokines that are crucial in 
fighting infection (Pruett, Zheng, Fan, Matthews, & Schwab, 2004), while also inducing pro-
inflammatory systemic cytokines such as TNF-α that can also impact the brain (Crews et al., 
2006). Furthermore, a study administering chronic ethanol to mice was able to confirm elevated 
pro-inflammatory cytokines, TNFα, IL-1β, IL-6, and MCP-1, contributed to the increased 
inflammation observed in the brain (Qin & Crews, 2012). There is still some ambiguity regarding 
the relationship between pro-inflammatory cytokine microglia activation after alcohol exposure 
and neurodegeneration, One study suggests a causal relationship (Qin et al., 2008; Qin & 
Crews, 2012), while another using a shorter ethanol exposure period observed 
neurodegeneration but only partial microglia activation (Marshall et al., 2013). It is then possible 
that microglia activation is a secondary mechanism following damage caused by ethanol or the 
neurodegeneration observed follow shorter bouts of ethanol exposure may be elicited by 
mechanisms other than neuroinflammatory responses.  
 While both TBI and alcohol consumption can have a detrimental impact on brain health, 
the effects of alcohol on TBI outcome are more complex and not well understood. Although the 
increased risk of sustaining a TBI when intoxicated is well established (Chen, Yi, Yoon, & Dong, 
2012), observational data regarding beneficial or detrimental effects of alcohol consumed prior 
to TBI is less clear. Some researchers report no relationship to outcome (Chen et al., 2012), 
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while others report a reduction in mortality for intoxicated patients with moderate to severe 
injuries (Brennan, Bernard, Cameron, Rosenfeld, & Mitra, 2015). It has been suggested that a 
confound exists in severity ratings for TBI intoxicated patients as the CNS depressant nature of 
alcohol would artificially lower the Glasgow rating scale used to assess the severity of injury in 
many medical settings potentially leading to decreases in mortality (O’Phelan, McArthur, Chang, 
Green, & Hovda, 2008). One study using an animal model of alcohol consumption prior to TBI, 
confirms previous reports of alcohol’s ability to suppress pro-inflammatory cytokines, but also 
showed an increased risk of mortality for intoxicated TBI subjects which was hypothesized  to 
be a result of increased susceptibility to infection (Greiffenstein, Mathis, Stouwe, & Molina, 
2007). This is in contrast to a study showing acute alcohol intoxication at the time of TBI 
delayed the resolution of neuroinflammatory cytokines (IL-1, IL-6, TNF-α, MCP-1) during TBI 
recovery (S X Teng & Molina, 2014). Alcohol consumption during the recovery period following 
a TBI appears to have predominately deleterious effects, but the mechanisms are still unknown 
(J. D. Corrigan, 1995; J. D. Corrigan et al., 2013). A recent study using ethanol vapor chamber 
exposure following mTBI showed increased astrocyte reactivity as well as microglia activation 
that correlated positively with greater deficits on neurological assessments of sensory, motor, 
reflexes, and balance skills (Sophie X. Teng et al., 2015).  
 
Hypotheses 
The proposed experiment investigated the combined effects of voluntary ethanol 
consumption following repetitive mTBI on the expression of the neuronal cytokine TFN-α as it is 
independently increased after TBI and alcohol consumption. It was hypothesized that increases 
in TNF-α expression would be greater following rmTBI compared to sham groups, but that 
ethanol consumption would lead to increased levels in both groups compared to controls.  
Length of the voluntary consumption period was hypothesized to positively correlate with 
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greater cytokine levels, therefore the cohort drinking for 8 weeks was expected to have the 
highest levels of TNF-α (He & Crews, 2008; Marshall et al., 2013; Ziebell & Morganti-Kossmann, 
2010).   
 
Methods 
 Brain tissue was collected from mice in Experiment 1 (n = 80, 10 samples per 
experimental condition) and an additional set of brains were extracted from a group of non-
manipulated mice (n =6) to determine TNF-α expression in drinking and non-drinking mice 
following rmTBI using real-time qPCR (Albert-Weißenberger et al., 2012; Yang et al., 2015).   
 
Real-time Polymerase Chain Reaction Assay 
RNA Isolation. Frozen brains were brought to room temperature; TRIzol (Invitrogen, 
Carlsbad, CA) was added and tissue was homogenized until no solid pieces were visible. 
Homogenized samples were incubated at room temperature for 5 minutes to allow for complete 
dissociation of the nucleoprotein complex. Chloroform was added to each sample, thoroughly 
mixed, and allowed to incubate another 2-3 minutes. The samples were then centrifuged at 
12,000g for 15 minutes at 4℃. The upper aqueous phase was removed and placed into a new 
collection tube. RNA purification occurred according to manufacturer protocol provided with 
PureLink RNA Mini Kit (Invitrogen, Carlsbad, CA). An aliquot (5ul) of RNA was diluted in 495ul 
of DEPC-treated water in order to measure RNA concentration and purity. Each sample was 
assessed with UV spectroscopy utilizing the absorbance measured at 260 and 280 nm 
(GENESYS Spectrometer, Thermo Scientific). The remainder of the RNA sample was stored at 
-80℃ until further use. 
cDNA Synthesis. The cDNA synthesis reaction was prepared according to 
manufacturer provided protocol included in the iScript Advanced cDNA Synthesis Kit for RT-
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qPCR (BioRad Laboratories, Hercules, CA). Briefly, a working solution was made using the 
provided 5x iScript Advanced Reaction mix, iScript Reverse Transcriptase, and water. The 
sample RNA template added to each well with the working solution. The samples went through 
reverse transcription by being held at 46℃ for 20min and then 1min at 95℃ to inactivate the 
reverse transcriptase. Samples were stored undiluted at -20℃ if not used for qPCR immediately.  
 qPCR. Quantitative PCR was conducted via manufacturer provided protocol for Sso 
Advanced Universal SYBR Green Supermix (BioRad Laboratories, Hercules, CA). Briefly, a 
working solution made using the provided SsoAdvanced Universal SYBR Green Supermix (2x), 
forward and reverse primers specific to the house gene (18S) or target gene (TNF-α), and 
nuclease-free H20. The samples were added to the plate in duplicate. Samples were then 
placed in iCycler MyIQ Real-Time PCR Detection System (BioRad Laboratories, Hercules, CA) 
and heated to protocol specified temperatures for 35 cycles.  
 
Analyses 
All analyses were conducted with SPSS 25.0 (IBM). A p-value less than 0.05 was set to 
evaluate significance unless otherwise indicated. Outliers were identified and removed following 
Tukey’s method creating boxplots and removing data points falling outside the ±1.5 interquartile 
range. Results of analyses that are not mentioned specifically are non-significant. 
Relative quantification of gene expression of TNF-α was calculated as fold change using 
the 2−ΔΔCT method (Livak & Schmittgen, 2001) comparing changes in house gene (18S) to target 
gene in controls and experimental groups. If the unknown from the experimental group exhibits 
a greater fold change relative to the housekeeping gene than the unknown for the control group, 
the conclusion is that the sample from the experimental group began with a larger quantity of 
DNA than did the sample from the control group. This would explain the difference in fold-
change between the groups. 
35 
 
In order to test the hypothesis that increases in the gene expression fold change of pro-
inflammatory cytokine, TNF-α, would be greater following rmTBI compared to sham groups, and 
that ethanol consumption would exacerbate the presence of these markers compared to 
controls, a one-way ANOVA, was conducted for each of the drinking cohorts (2, 4, 6, and 8 
Weeks).   
 
Results 
For each cohort, a one-way ANOVA was conducted to compare gene expression fold 
change in TNF- α expression; results are displayed in Table 1 and Figure 1. This revealed a 
significant effect in the 2 Week cohort, F(2, 20) = 4.489, p < .05. Post-hoc analyses using 
Bonferroni correction indicated a greater fold change in the Sham group, (M= 2.669) compared 
to the Control group (M = 1.020); this suggests there were similar amounts of DNA in the control 
condition relative the housekeeping gene, but the Sham group showed more than a 2.5x 
increase in relative quantity of DNA. In the 4 Week cohort, there was also a significant effect, 
F(2, 15) = 5.811, p < .05. Post-hoc analyses using Bonferroni correction also showed a larger 
fold change in Sham (M= 2.182) compared to Control (M = 1.134). There was also a significant 
effect in the 6 Week cohort, F(2, 18) = 10.317, p < .05. Post-hoc analyses using Bonferroni 
correction found a greater fold change from in the Sham group (M= 2.523) compared to Control 
(M = .735) and rmTBI (M = .894) groups. There were no significant differences in TNF- α fold 
change gene expression in the 8 Week cohort.   
In summary, there is insufficient evidence to support a compounded elevation in TNF- α 
expression due to the combined effects of rmTBI and ethanol consumption. Instead, in the 2, 4, 
and 6 Week cohorts, fold change in TNF- α expression was elevated in Sham mice compared to 
controls presumably due to ethanol consumption. Both rmTBI and Sham groups in the 8 Week 
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cohort showed a return to baseline levels. Possible explanations of these phenomena are 
included in the discussion.  
 
Table 1. TNF- α Fold Change Expression Means by Cohort 
 2 Week 4 Week 6 Week 8 Week 
Condition M SD N M SD N M SD N M SD N 
Control  1.02 .23 4 1.13 .57 5 .74 .28 4 .77 .10 4 
Sham 2.67 1.24 10 2.18* .34 6 2.52* .97 7 .59 .48 8 
rmTBI 1.97 .70 9 1.45 .62 7 .89** .79 10 .54 .30 6 
*denotes significant difference from Control at the 0.05 level. ** denotes significant difference between Sham and 
rmTBI at the 0.05 level 
 
A B 
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Figure 1. TNF- α Fold Change Expression Means by Cohort.  
A) 2 Week Cohort, B) 4 Week Cohort, C) 6 Week Cohort, D) 8 Week Cohort 
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Discussion 
 Expression of TNF- α observed in the Sham groups compared to Controls in the 2, 4, 
and 6 Week cohorts were elevated likely due to ethanol consumption as predicted. Yet despite 
the rmTBI cohorts also voluntarily consuming ethanol, there was not a significant difference 
from Controls in any of the cohorts. This was somewhat surprising given other researchers 
accounts of increased TNF- α expression following TBI. In fact, due to both TBI and ethanol 
consumption independently increasing TNF- α expression, it was expected that there would be 
elevated levels in the rmTBI Drinking groups compared to Sham. Expression of TNF- α in the 
rmTBI groups were slightly elevated from controls in the 2 and 4 Week cohorts, but in the 6 
Week group, the levels have returned to control levels. All TNF- α expression returned to control 
levels in the 8 Week cohort despite continued ethanol consumption.   
Other researchers have shown suppression of pro-inflammatory cytokines when alcohol 
was administered prior to injury, so it is possible that the observed findings suggest ethanol 
attenuated the expression of TNF- α in the TBI group (Greiffenstein et al., 2007). However, 
others show an exacerbated response for neuroinflammatory cytokines (IL-1, IL-6, TNF-α, MCP-
1) when alcohol was present at the time of TBI (S X Teng & Molina, 2014). Cytokines are often 
released in a cascade, some showing pro-inflammatory effects, others anti-inflammatory effects, 
and some have more diverse functions (Tisoncik et al., 2012). It is entirely possible that a more 
holistic approach would yield a better understanding of the recruitment and resolution of the 
cytokines in response to rmTBI, alcohol, and the combination. While it is beyond the scope of 
the current study, it is possible that the brain’s response to TBI included anti-inflammatory 
cytokines also, that contributed to a prolonged reduction of TNF- α expression despite 
continued ethanol consumption in the TBI group. 
 
 
38 
 
Conclusions  
The current literature regarding the combined effects of rmTBI and voluntary ethanol 
consumption on neuroinflammatory effects is inconsistent in that some evidence suggests 
alcohol suppresses neuroinflammatory cytokine production and other research finds support for 
the prolonged elevation of cytokine levels. Given the varied effects of cytokines and the intricate 
cascades recruiting them to sites of neural insult, it is likely that single assessment approaches 
like the one used here are somewhat limited in the greater understanding of recovery from TBI. 
Future studies should consider examining other pro-inflammatory cytokines like those that have 
been previously observed after TBI or alcohol consumption such as IL-1β, IL-6, IL-8/MIP, IL-10, 
and MCP-1 simultaneously in each sample. Likewise, it would be useful to investigate microglia 
and neuron specific recruitment of the pro-inflammatory cytokines to better understand the 
specific targets of the pro-inflammatory cytokines. 
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EXPERIMENT 3: COMBINED EFFECTS OF REPETITIVE MILD TRAUMATIC BRAIN INJURY 
AND CHRONIC ALCOHOL CONSUMPTION ON COGNITION AND BEHAVIOR  
 
Each year an estimated 1.5 million Americans seek medical attention for a traumatic 
brain injury (TBI) while many more injuries go unreported altogether (Faul M, Xu L, Wald MM, 
2010; Niska et al., 2010). Even still, the economic impact to treat TBI is nearly $40 billion dollars 
annually (Silver et al., 2001). The majority of these injuries are considered mild and are difficult 
to observe using MRI or CT scans that are the current standard for brain imaging (Delouche et 
al., 2015). Despite the relatively minor physical damage to brain tissue, symptoms include 
headache, dizziness, impaired memory, confusion, irritability, fatigue, and poor concentration 
(Alexander, 1995; Karr, Areshenkoff, & Garcia-Barrera, 2014; National Center for Injury 
Prevention and Control, 2003).  
 Many studies and meta-analyses show mTBI patients generally show full cognitive, 
behavioral, and cerebral glucose metabolic recovery by 3 months post-injury (Belanger, Curtiss, 
Demery, Lebowitz, & Vanderploeg, 2005; Karr et al., 2014; Weil, Gaier, & Karelina, 2014). 
However, 10-15% of patients with mTBI do not show recovery and continue to present with 
headache, neck pain, or dizziness, characteristics of symptomatic persistent post-concussive 
syndrome (PPCS) which is a more permanent form of post-concussive syndrome (PCS) 
(Alexander, 1995). Cognitive symptoms of PPCS are similar to initial cognitive complaints and 
include problems with attention, impaired memory, and other reduced executive functions 
(Alexander, 1995; Ashman et al., 2006; Belanger et al., 2005; Harmon et al., 2013; Holm et al., 
2005; Vagnozzi et al., 2010). Recovery can be prolonged by additional disturbances to the brain 
during the initial recovery period of mTBI (e.g. a second mTBI, extreme physical exertion; 
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Ashman et al., 2006; Goodman et al., 2013; Harmon et al., 2013; Prins et al., 2011; Solomon & 
Zuckerman, 2015; Weil et al., 2014).  
 Alcohol use can also greatly impact an individual’s recovery from TBI and lead to greater 
risk of incurring additional TBIs (Corrigan et al., 2013). Increased drinking following a TBI can be 
predicted by history of use prior to the injury (Bombardier et al., 2003; Dikmen et al., 1995; 
Horner et al., 2005; Rogers & Read, 2007), but can also occur in patients who had never had 
substance abuse disorder in either civilian (J. D. Corrigan, 1995; Hibbard et al., 1998; Massagli 
et al., 2004; Silver et al., 2001) or military populations (Adams et al., 2013; Herrold  A. et al., 
2014; Miller & Baktash, 2013; Tanielian, T., Jaycox, 2008). Regardless of previous drinking 
history, heavy alcohol consumption during recovery of TBI can lead to delayed recovery and 
detrimental outcomes in terms of health, interpersonal relationships, and psychological well-
being (J. D. Corrigan, 1995). It is not surprising that patients can experience substance use 
disorders following TBI, as there is an increase in a number of other psychological disorders 
including depression/mood disorders, post-traumatic stress disorder, and anxiety disorders 
(Hibbard et al., 1998; Jorge et al., 2005; Silver et al., 2001).  
 Alcohol use disorders can be devastating to a person’s health, finances, and 
interpersonal relationships and can co-occur with other mental health disorders independently of 
TBI (Center for Behavioral Health Statistics and Quality, 2015). Since heavy drinking following a 
TBI can increase recovery times, potentially due to additional damage via neuroinflammation or 
other mechanisms (Crews et al., 2006; Ghirnikar et al., 1998; He & Crews, 2008), it is important 
to determine how drinking influences cognitive and behavioral performance in those with TBI. 
Animal models of repetitive mTBI have already demonstrated poorer cognitive and behavioral 
outcomes after multiple mTBIs (Prins et al., 2011; Yang et al., 2015). However, researchers 
have found mixed results on cognitive performance when ethanol was administered prior to or 
following acute and repetitive mTBI in rodent models. For example, one group of researchers 
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found no effects on neurological or behavioral outcomes when ethanol was administered prior to 
acute mTBI (S X Teng & Molina, 2014), and others showed delayed recovery of sensorimotor 
function (Vaagenes et al., 2015). Others have found that ethanol administered chronically after 
mTBI, produced mild neurological deficits, impaired memory on a novel object recognition task, 
and decreased locomotor activity (Mayeux et al., 2015; Sophie X. Teng et al., 2015). This study 
sought to contribute to the growing body of literature by investigating the effects of voluntary 
alcohol consumption following repetitive mTBI in rodent models on cognitive and behavioral 
performance using the open field exploration test, novelty preference, novel object recognition, 
and the serial spatial discrimination reversal learning task (SSDRL, a measure of behavioral 
flexibility).  
 
Hypotheses 
Previous literature has demonstrated deficits in behavioral flexibility after high dose 
ethanol administration in mice (Badanich, Becker, & Woodward, 2011) and various 
cognitive/behavioral deficits following mTBI have been reported (Prins et al., 2011; Yang et al., 
2015), therefore it was hypothesized that all would mice show deficits on the behavioral 
flexibility task due to ethanol consumption, but those injured would have greater deficits 
including worse performance on the novel object recognition task.    
  
Methods 
 
Voluntary Ethanol Consumption  
The same model of repetitive mTBI and ethanol voluntary consumption described in 
Experiment 1 was used again. A total of 216 (8-12 weeks old) male C57BL/6J mice (Envigo 
Laboratories, Indianapolis, IN, USA) were tested (n = 12 mice per condition, rmTBI or sham) 
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after 0, 2, 4, 6, and 8 weeks of ethanol exposure or no ethanol exposure. Two days following 
the last ethanol exposure, mice were subjected to a battery of cognitive-behavioral tasks over 
six days to determine how excessive drinking after a rmTBI effects cognitive performance. All 
behavior was recorded and analyzed using Any-maze video tracking software (Stoelting Co., IL, 
USA).   
 
Cognitive and Behavioral Measures  
Cognitive and behavioral tasks include the behavioral flexibility task, SSDRL, open field 
test (OF), novelty preference, and novel object recognition (NOR). The SSDRL task is a general 
measure of global cognitive function and behavioral flexibility. It requires the mice to learn a 
strategy using spatial cues, recognize when this strategy no longer works, and switch to a new 
strategy. The OF test provided a measure of general locomotor activity after habituating to a 
new environment. Novel object recognition served as a measure of novelty preference and 
working memory function; for a detailed outline of the schedule see Table 1.  
 
Table 1. Experiment 3 Cognitive Assessment Schedule 
Day 1 SSDRL: Pretrial training (10 trials) 
Day 2 SSDRL: Test Day (30 trials) 
Day 3 SSDRL: Test Day (30 trials) 
Day 4 SSDRL: Test day (30 trials) 
Day 5 Open Field: Open field habituation/behavioral reaction to the novel environment for 3 
min in a normal open field (Trial 1). 30min Delay. Open Field: 3 min open field 
exposure test (Trial 2) to test locomotor activity. 
Day 6 Novelty Preference, and Novel Object Recognition: One 3 min open field exposure 
test (Trial 3) with a novel object in the center to measure novelty preference. After a 
30min delay, a final 3 min trial in the open field area with the familiar object and a new 
object to gage object recognition (Trial 4). 
 
Serial Spatial Discrimination Reversal Learning. Using a partially submerged T-Maze 
(overall upper arm length 24in, arm width 3-3.5 in, base leg length 15in, wall height 15in), mice 
were required to learn to escape from the water (24-26°C, dyed opaque with non-toxic, water-
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soluble white paint) using a platform at one of the arms. The first day of this task there was a 
pre-trial training session to habituate the mice to the task. The arms of the T-Maze are blocked 
in a pseudorandom order ensuring the mice have learned to escape from both sides of the 
maze at least five times prior to testing. During the subsequent three days of testing, mice 
learned to escape by remembering the location of the escape platform to be on the left or right 
arm of the maze. Once a rule has been sufficiently learned (criterion of six correct choices with 
no errors), the rule was reversed so that the platform was on the other side of the maze. The 
mice completed 30 trials per day and were kept in a warmed environment (approximately 31°C) 
between trials (1 to 2 inter-trial minute intervals) to prevent hypothermia. 
All animals started testing on their non-preferred arm. This was determined by allowing 
the animal to choose freely between the two arms on the first test trial and placing the escape 
platform in the opposite arm. Errors included entering the incorrect arm, re-entry to the starting 
stem, and backtracking through the correct arm without escaping. Because the criterion to 
reverse the contingencies was six correct trials, if an animal completed two consecutive trials 
during the final trials of the day, an additional four trials were added in an attempt to allow the 
animal to reach the criterion. If the mouse made an error during one of the extra trials, testing 
ended for the day.  
Open Field with Novelty Task and Recognition Task. These tasks assessed 
locomotor activity (distance traveled, time spent in the center), preference for novelty, and 
working memory (via recognition of familiar object and time spent with novel object).  
On day 5, mice freely explored the OF arena for 3 min to habituate to the environment; 
approximately 30 minutes later an additional 3 min session took place to monitor the animals 
locomotor activity. On day 6, a 3 min exploration included a novel object. After a 30min delay, a 
second object was also added to the arena and the mouse was allowed another 3 min to 
explore. All objects used were no more than twice the size of the mice and did not resemble 
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living stimuli (e.g. no animal shapes or eyes). The arena and all objects were cleaned with 40% 
ethanol wipes to sanitize and deodorize between animals.  
 
Analyses 
All analyses were conducted with SPSS 25.0 (IBM). A p-value of less than 0.05 was set 
to evaluate significance unless otherwise indicated. Outliers were identified and removed 
following Tukey’s method creating boxplots and removing data points falling outside the ±1.5 
interquartile range. Results of analyses that are not mentioned specifically are non-significant. 
In order to test the prediction that mice with rmTBI would perform more poorly on the 
SSDRL compared to sham mice, an ANOVA was used to compare performance scores of 
rmTBI and sham groups for each cohort (0, 2, 4, 6, or 8 weeks). Poorer performance on this 
task was determined by an increased number of trials to reach criterion, increased number of 
errors, and fewer successful reversals of strategy.   
  In order to test the impact of injury on locomotor activity in the open field paradigm, the 
average distance traveled in Trial 2 of the open field series was determined using Any-maze 
video tracking software.  An ANOVA was used to compare performance scores of rmTBI and 
sham groups for each cohort (0, 2, 4, 6, or 8 weeks). In order to test the prediction that memory 
performance during the novel object recognition task would be impaired due to rmTBI, an 
ANOVA was conducted examining the relative time spent with the novel object compared to the 
familiar object for each cohort. 
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Results 
 
Voluntary Consumption 
A 2 x 2 Procedure (rmTBI, Sham) x Week (1, 2) mixed ANOVA was conducted to 
determine whether there were differences in average daily consumption of ethanol in the 2 
Week cohort.  Results shown in Figure 1, indicated a significant main effect of Week, F(1, 38) = 
6.422, p < .05, and Bonferroni corrected pairwise comparisons showed mice drank less ethanol 
in Week 2 (M= 1.45g/kg) compared to Week 1 (M = 2.00g/kg). A 2 x 2, Procedure (rmTBI, 
Sham) x Week (1, 2) mixed ANOVA was used to examine differences in daily ethanol 
preference. Results revealed a significant main effect of Procedure, F(1, 38) = 5.072, p < .05, 
and Bonferroni adjusted pairwise comparison showed rmTBI to cause a decreased ethanol 
preference in rmTBI mice (M = 75.1%) compared to Sham mice (M = 84.3%).  
 
A B   
 
 
 
 
Figure 1. Experiment 3 Ethanol Intake – 2 Week Cohort 
A) Average daily voluntary ethanol consumption and B) ethanol preference in the 2 Week 
Cohort.  
 
In the 4 Week cohort, a 2 x 4 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4) mixed 
ANOVA was used to determine differences in average daily consumption of ethanol (g/kg). 
Results, as shown in Figure 2, revealed significant main effects of both Week, F(3, 78) = 6.47, p 
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< .05 and Procedure, F(1, 78) = 11.45, p < .05. Pairwise comparison using Bonferroni 
corrections indicated mice consumed less ethanol in Week 2 (M = 1.50g/kg) and Week 3 (M = 
1.36g/kg) compared to Week 1 (M= 2.16g/kg), and recovered to initial levels in Week 4 (M = 
1.91g/kg). Across time, rmTBI mice consumed less ethanol (M = 1.49g/kg) compared to Sham 
(M = 1.98g/kg). In order to evaluate the decreased ethanol consumption observed in the 4 
Week cohort, a 2 x 4 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4) mixed ANOVA was used to 
examine total fluid (ethanol and water) intake (ml). Results showed a decrease in the total fluid 
consumed that corresponds with the decrease in rmTBI specific ethanol (g/kg) consumption 
during Week 2, F(3, 78) = 4.363, p < .05 suggesting the decrease in ethanol consumption 
coincides with a total decrease in fluid intake by rmTBI mice during Week 2.  
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Figure 2. Experiment 3 Ethanol Intake – 4 Week Cohort 
A) Average daily voluntary ethanol consumption and B) ethanol preference in the 4 Week 
Cohort.  
 
Additionally, to examine differences in average ethanol preference a 2 x 4 Procedure 
(rmTBI, Sham) x Week (1, 2, 3, 4) mixed ANOVA was conducted and revealed a significant 
main effect of TBI, F(1, 78) = 8.890, p < .05. Bonferroni adjusted pairwise comparison showed a 
decrease in ethanol preference for rmTBI mice (M = 73.1%) compared to Sham (M = 82.2%).   
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 A 2 x 6 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4, 5, 6) mixed ANOVA examining 
average ethanol consumption and another comparing average ethanol preference in the 6 
Week cohort did not reveal any differences across weeks or between the TBI and Sham 
conditions; results illustrated in Figure 3.  
 
A B  
 
 
 
Figure 3. Experiment 3 Ethanol Intake – 6 Week Cohort 
A) Average daily voluntary ethanol consumption and B) ethanol preference in the 6 Week 
Cohort.  
 
In the Week 8 cohort, 2 x 8 Procedure (rmTBI, Sham) x Week (1, 2, 3, 4, 5, 6, 7, 8) 
mixed ANOVA comparing average ethanol consumption (g/kg) did not show any significant 
differences, but when an additional analysis was conducted examining differences in ethanol 
preference, a main effect of Procedure was found, F(1, 160) = 28.432, p < .05. As shown in 
Figure 4, pairwise comparison using Bonferroni corrections revealed rmTBI mice had a greater 
preference for ethanol (M = 87.2%) compared to Sham (M = 76.4%).  
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Figure 4. Experiment 3 Ethanol Intake – 8 Week Cohort 
A) Average daily voluntary ethanol consumption and B) ethanol preference in the 8 Week 
Cohort.  
 
Although in the 8 Week cohort rmTBI mice exhibited a unique increase in ethanol 
preference, the effects of rmTBI on voluntary ethanol consumption in the 2, 4 and 6 weeks 
cohorts were similar to what was observed in Experiment 1. Again, there was insufficient 
evidence to support the hypothesis that rmTBI leads to increased ethanol drinking and 
preference, and instead, the data indicate rmTBI may decrease ethanol consumption during 
weeks 2 and 3 specifically as observed in the 4 Week cohort.  
 
Cognitive and Behavioral Testing 
To make the results of the SSDRL task more tenable, in each cohort, the group mean for 
the Sham, No Ethanol group during the simple discrimination task was set to 100% baseline for 
both “Trials to Criterion” and “Errors to Criterion” measures. The percent difference from 
baseline was analyzed to determine effects of the Task (Simple Discrimination or Reversal 
Learning), TBI, and Ethanol Exposure via repeated measures ANOVA for each cohort.  
Measures of locomotor activity were analyzed for differences in distance traveled (See 
Table 2), and the percent time spent in the center of the OF arena for TBI and Ethanol Exposure 
for each cohort (0 Week, 2 Week, 4 Week, 6 Week, 8 Week). Additionally, novel object 
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recognition was measured by comparing the percentage of time spent with a novel object or 
familiar object by TBI and Ethanol Exposure for each cohort (0 Week, 2 Week, 4 Week, 6 Week, 
8 Week). 
 
Table 2. Distance Travelled (m) 
 0 Week 2 Week 4 Week 6 Week 8 Week 
Condition M SD N M SD N M SD N M SD N M SD N 
Sham, No Drinking  5.6 1.6 12 6.8 1.6 12 5.7 1.7 12 6.8 1.9 12 6.5 2.2 12 
Sham, Drinking -- -- -- 6.4 1.6 12 7.2 1.5 12 6.4 2.3 12 4.8 2.7 11 
TBI, No Drinking 5.8 2.0 12 6.9 2.4 12 7.2 1.9 12 7.7 1.7 12 5.5 1.4 12 
TBI, Drinking -- -- -- 6.8 2.3 11 7.1 1.7 11 6.5 1.8 11 6.1 1.7 12 
Locomotor activity – distance tables 
 
0 Week Cohort. The 0 Week cohort was tested following the rmTBI or sham procedure 
period and therefore were not exposed to ethanol. A repeated measures ANOVA was used to 
determine differences in the percentage of trials to criterion and revealed a significant main 
effect of Task, F(1, 18) = 18.396, p < .05. As shown in Figure 5, mice displayed an increased 
percentage of trials necessary to meet learning criteria during the Reversal task (180.2%) 
compared to the Simple Discrimination trial (M = 104.4%). A repeated measures ANOVA 
analysis to compare the percentage of errors relative to the Sham, No Ethanol group found a 
similar result with a main effect of Task F(1, 18) = 40.018, p < .05. Adjusted pairwise 
comparisons also showed mice had an increased percentage of errors in Reversal (M = 
446.7%) compared to Simple Discrimination (M = 104.4%). These findings verify the difficulty of 
reversal learning in both Sham and rmTBI mice and indicate that rmTBI by itself did not 
significantly alter behavioral flexibility 3 days following the final rmTBI exposure. No differences 
were observed for distance traveled, time spent in the center, or time spent with the novel 
object.  
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Figure 5. Cognition and Behavior for 0 Week Cohort 
Panel A) Percentage of trials to criterion B) Percentage of errors during criterion, C) Percent 
time spent in center during locomotor activity trial, D) Percent time spent with novel object vs 
familiar object 
 
2 Week Cohort. Results are illustrated in Figure 6. To determine differences in the 
percentage of trials to criterion in the 2 Week cohort, a repeated measures ANOVA was 
conducted. Results indicated a significant main effect of Task, F(1, 38) = 16.027, p < .05; 
however, this effect was qualified by a significant three-way interaction of Task x Procedure x 
Ethanol Exposure, F (1, 38) = 7.628, p < .05. Bonferroni adjusted pairwise comparisons 
revealed that mice in the rmTBI, No Ethanol group displayed an increase in the percentage of 
trials to criterion from the Simple Discrimination task (M = 69.4%) to the Reversal task (M = 
168.6%). Additionally, mice in the rmTBI, Ethanol group required a greater percentage of trials 
to reach criterion during Simple Discrimination (M = 134.4%) than the rmTBI, No Ethanol group 
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(M = 69.4.4%). Finally, mice in the rmTBI, No Ethanol group displayed an increase in percent 
trials to Reversal (M = 168.6%) compared to the Sham, No Ethanol group (M = 90.1%).  
To determine whether there were differences in the percentage of errors made, repeated 
measures ANOVA was conducted. Results revealed a significant main effect of Task, F(1, 38) = 
36.904, p < .05; however, this effect was qualified by a significant three-way interaction of Task 
x Procedure x Ethanol Exposure, F (1, 38) = 7.303, p < .05. Corrected pairwise comparisons 
showed an increase in percent errors for the Sham, Ethanol group from simple discrimination (M 
= 79.8%) to reversal (M = 183.5%), as well as for the TBI, No Ethanol group from simple 
discrimination (M = 49.2%) to reversal (M = 309.7%). Additionally, mice in the rmTBI, Ethanol 
group committed a larger percentage of errors before reaching criterion during simple 
discrimination (M = 155.7%) compared to the rmTBI, No Ethanol (M = 49.2.0%). Finally, mice in 
the rmTBI, No Ethanol group showed an increase in percent errors during reversal (M = 
309.7%) compared to the Sham, No Ethanol group (M = 170.9%). No differences were 
observed for distance traveled, time spent in the center, or time spent with the novel object. 
These findings suggest that 2 weeks following the final rmTBI exposure, mice in the rmTBI 
group exhibit some increased difficulty in both learning a simple discrimination and behavioral 
flexibility and that 2 weeks of ethanol exposure may exacerbate difficulties in learning a simple 
discrimination 2 weeks following rmTBI. 
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Figure 6. Cognition and Behavior for 2 Week Cohort 
Panel A) Percentage of trials to criterion B) Percentage of errors during criterion, C) Percent 
time spent in center during locomotor activity trial, D) Percent time spent with novel object vs 
familiar object 
 
4 Week Cohort. To determine differences in the percentage of trials to criterion in the 4 
Week cohort, a repeated measures ANOVA was conducted and revealed a significant main 
effect of Task F(1, 38) = 10.026, p < .05. As illustrated in Figure 7, corrected pairwise 
comparisons showed mice required an increase in the percentage of trials to complete the 
Reversal task (122.2%) compared to the Simple Discrimination task (M = 93.3%). The repeated 
measures ANOVA used to compare the percentage of errors produce a similar finding with a 
main effect of Task F(1, 38) = 35.468, p < .05. Adjusted pairwise comparisons again showed an 
increased difficulty (more errors) to complete the Reversal task (M = 207.4%) compared to the 
Simple Discrimination task (M = 87.7%). Therefore, 4 weeks following rmTBI or a sham 
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procedure, mice given water or exposed to ethanol exhibited typical difficulties with behavioral 
flexibility. 
To examine differences in novelty preference in the novel object recognition task, a 2 x 
2, Procedure (rmTBI, Sham) x Ethanol Exposure (Drinking, No Drinking) ANOVA comparing 
percent time spent with a novel object vs a familiar object was conducted and revealed a main 
effect of Procedure, F(1 , 43) = 4.138, p < .05, as well as, a main effect for Ethanol Exposure, 
F(1 , 43) = 10.519, p < .05.  Bonferroni corrected pairwise comparisons indicated that rmTBI 
mice spent a greater percentage of time with the novel object (M = 65.2%) than Sham mice (M 
= 52.2%). Pairwise comparisons for Ethanol Exposure indicated the mice that drank ethanol 
generally spent a greater percentage of time with the novel object (M = 69.1%) compared to 
those that did not drink ethanol (M =48.3%. These findings indicate that novelty preference is 
elevated 4 weeks following the final rmTBI procedure and that 4 weeks of ethanol exposure 
produces similar effects, but do not support the hypothesis that ethanol exposure exacerbates 
that effects of rmTBI on novelty preference. 
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Figure 7. Cognition and Behavior for 4 Week Cohort 
Panel A) Percentage of trials to criterion B) Percentage of errors during criterion, C) Percent 
time spent in center during locomotor activity trial, D) Percent time spent with novel object vs 
familiar object 
 
6 Week Cohort. To determine differences in the percentage of trials to criterion in the 6 
Week cohort, a repeated measures ANOVA was conducted and revealed a significant main 
effect of Task, F(1, 36) = 11.476, p < .05, and a significant Task by Procedure interaction, F(1, 
35) = 4.978, p < .05; however, these effects were qualified by a significant three-way interaction 
of Task x Procedure x Ethanol Exposure, F (1, 36) = 6.516, p < .05. As illustrated in Figure 8, 
Bonferroni adjusted pairwise comparisons indicated that mice in the Sham, No Ethanol group 
showed an increased percentage of trials required to complete the Reversal task (M = 163.4%) 
compared to the Simple Discrimination task (M = 100.0%). The same effect was noted for the 
rmTBI, Ethanol mice when comparing Simple Discrimination (M = 78.8%) to Reversal (M = 
117.9%). Additionally, mice in the rmTBI, No Ethanol showed increased difficulty completing the 
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Simple Discrimination task (M = 133.4%) compared to the rmTBI, Ethanol group (M = 78.8%). 
Finally, mice in the Sham, No Ethanol group showed increased difficulty with behavioral 
flexibility when comparing the percentage of trials to criterion for the Reversal task (M = 
163.4%) to the rmTBI, No Ethanol group (M = 114.2%). 
 To examine differences in the percentage of errors committed during a task, a repeated 
measures ANOVA was conducted and revealed a significant main effect of Task, F(1, 36) = 
56.961, p < .05, and a significant Task by Procedure interaction, F(1, 35) = 7.102, p < .05; 
however, these effects were qualified by a significant three-way interaction of Task x Procedure 
x Ethanol Exposure, F (1, 36) = 6.041, p < .05. Corrected pairwise comparisons showed mice in 
the Sham, No Ethanol group committed more errors during the Reversal task (M = 339.1%) 
compared to Simple Discrimination (M = 100.0%). This was also true for the Sham, Ethanol 
group when comparing percentage of errors in Reversal (M = 262.9%) and Simple 
Discrimination (M = 131.4%), as well as for mice in the rmTBI, Ethanol group, showing an 
increase in percentage of errors during Reversal (M = 223.0%) when compared to Simple 
Discrimination (M = 99.1%). Although rmTBI, No Ethanol mice did not exhibit a greater 
percentage of errors during reversal when compared to simple discrimination, these mice 
produced a higher percentage of  errors (M = 185.7%) while completing the Simple 
Discrimination task than either the Sham, No Ethanol group (M = 100.0%) or the TBI, Ethanol 
group (M = 99.1%), indicating cognitive impairment. Interestingly, the rmTBI, No Ethanol group 
produced a lower percentage of errors during Reversal (M = 239.0%) when compared to the 
Sham, No Ethanol group (M = 339.1%), but this was accompanied by an impairment of simple 
discrimination suggesting increased difficulty with learning a simple discrimination in the rmTBI, 
No Ethanol group. No differences were observed for distance traveled, time spent in the center 
or time spent with the novel object.  
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Figure 8. Cognition and Behavior for 6 Week Cohort 
Panel A) Percentage of trials to criterion B) Percentage of errors during criterion, C) Percent 
time spent in center during locomotor activity trial, D) Percent time spent with novel object vs 
familiar object 
 
8 Week Cohort. To determine differences in the percentage of trials to criterion in the 8 
Week cohort, a repeated measures ANOVA was used and found a significant main effect of 
Task, F (1, 35) = 12.891, p < .05. As shown in Figure 9, Bonferroni adjusted pairwise 
comparisons confirmed mice required an increased percentage of trials to complete the 
Reversal task (167.3%) compared to the Simple Discrimination task (M = 110.4%). 
 To examine differences in the percentage of errors committed during a task, a repeated 
measures ANOVA was conducted and showed a significant main effect of Task, F(1, 35) = 
37.484, p < .05; however, this effect was qualified by a significant three-way interaction between 
Task, rmTBI, and Ethanol Exposure, F (1, 38) = 6.267, p < .05. Corrected pairwise comparisons 
show mice in the Sham, No Ethanol group committed more errors in the Reversal task (M = 
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395.8%) compared to the Simple Discrimination task (M = 100.0%).  Likewise, the Sham, 
Ethanol mice showed an increase in percentage of errors during the Reversal task (M = 
276.3%) compared to the Simple Discrimination task (M = 147.0%) and the TBI, Ethanol group 
displayed a similar increased percentage of errors committed during Reversal (M = 371.4%) 
compared to Simple Discrimination (M = 138.7%). Mice in the rmTBI, No Ethanol group did not 
exhibit a greater percentage of errors during reversal than during simple discrimination which is 
suggestive of difficulty with learning the simple discrimination task. However, the rmTBI, No 
Ethanol group also produced a smaller percentage of errors (M = 199.3%) during reversal when 
compared to the Sham, No Ethanol group (M = 395.8%) or the TBI, Ethanol group (M = 
371.4%), suggesting less difficulty with behavioral flexibility than the other groups.  
To examine differences in novelty preference in the novel object recognition task, a 2 x 
2, Procedure (rmTBI, Sham) x Ethanol Exposure (Drinking, No Drinking) ANOVA comparing 
percent time spent with a novel object vs a familiar object was conducted and revealed a main 
effect of Ethanol Exposure, F(1, 42) = 6.995, p < .05.  Bonferroni correct pairwise comparisons 
showed Ethanol exposed mice spent more time with the novel object (M = 72.9%) compared to 
the No Ethanol group (M =54.9%).  
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Figure 9. Cognition and Behavior for 8 Week Cohort 
Panel A) Percentage of trials to criterion B) Percentage of errors during criterion, C) Percent 
time spent in center during locomotor activity trial, D) Percent time spent with novel object vs 
familiar object 
 
In summary, the SSDRL task provided a valid measure of behavioral flexibility by 
demonstrating a general capacity for learning a simple discrimination task and increased 
difficulty with reversal learning. Inconsistent patterns of cognitive deficits were observed in the 2, 
6 and 8 Week cohorts. This suggests nature of cognitive dysfunction related to rmTBI and 
voluntary ethanol exposure is perhaps transient and difficult to elicit consistently in animal 
models.  The specific cognitive deficits observed came in the form of general learning 
dysfunction as indicated by increased difficulty learning the initial simple discrimination task, and 
deficits in behavioral flexibility assessed with performance on the reversal learning task. Ethanol 
exposure, rmTBI, or the combination did not consistently produce deficits in general learning or 
behavioral flexibility, rather the observed effects varied by cohort. For example in the 2 Week 
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cohort the rmTBI, Drinking group experienced general difficulty learning and the rmTBI, No 
Drinking group only displayed a strong deficit in behavioral flexibility. However, in the 6 Week 
cohort, the rmTBI, No Drinking group displayed general learning deficits and the rmTBI, Drinking 
group showed specific deficits in behavioral flexibility. In the 8 Week cohort, deficits in cognition 
can only be observed with the more sensitive measure of errors during each task, and suggest 
a more lasting rmTBI dependent effect for the rmTBI, Drinking group. 
In general, the lack of evidence for differences between groups on the measures of 
distance traveled and time spent in center suggest there may not be lasting locomotor effects 
that bias the novel object recognition task or create notable anxiety dependent effects that 
would inhibit the mice from exploring the objects when placed in the center. The exception is for 
the 0 Week cohort tested following the rmTBI procedures, as this group did have notably lower 
percentages of time spent in center suggesting a possible increase in anxiety that also 
subsequently impacted the times spent with the novel objects. These animals had fewer 
interactions with humans as the nature of their assigned cohort (0 Week ethanol exposure) 
dictated a less total time in the colony. For the remaining cohorts, the novel object recognition 
task performance provided some support for the hypothesis predicting ethanol dependent 
increases in novelty preference. Specifically, increases in novelty preference due to ethanol 
consumption were observed in the 4 and 8 Week cohorts, and an additional influence of rmTBI 
on increased novelty seeking was present in the 4 Week cohort.  
 
Discussion 
 The voluntary ethanol consumption and ethanol preference outcomes in this study 
generally support the transient effect of decreased intake and preference following repetitive 
mTBI first observed in Experiment 1.  The ethanol consumption volumes also confirm a 
decrease in weekly variation as drinking levels stabilize over time.  
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The primary focus of this study was to investigate the cognitive and behavioral outcomes 
following the repetitive TBI or sham procedure combined with the voluntary consumption or 
waiting period. To do this, the SSDRL task was used to assess an animal’s ability to learn a rule 
in a T-Maze swimming task, and then measure behavioral flexibility when that rule was changed 
unexpectedly. This was followed by an open field series investigating anxiety effects (decreased 
time spent in the center), and novelty preference as observed in a novel recognition paradigm.  
There were no significant differences in distance traveled or time spent in the center for 
any of the cohorts, but a general increase in distance traveled and time spent in the center was 
observed as the cohorts’ drinking or resting period increased. These effects may be due to 
increased handling and human exposure over time.  
When there were no effects of TBI or Ethanol Exposure for the SSDRL paradigm as in 
the 0 Week and 4 Week cohorts, there was still increased difficulty observed when the mice 
were trying to reverse the previously learned simple discrimination task. The increased number 
of trials to criterion and errors during reversal learning help validate the assumption that 
behavioral flexibility is more challenging than simple discrimination learning. 
More interestingly, in the 2 Week cohort, an increased difficulty with behavioral flexibility 
was observed in the TBI, No Ethanol group suggesting impairment due to TBI. However, a more 
non-specific difficulty with learning was noted in the TBI, Ethanol group as shown by deficits 
when learning both the simple discrimination and reversal tasks. This was supported by both the 
number of trials to reach criterion and the number of errors committed during each task. In the 
Week 6 cohort, non-specific deficits were observed in the TBI, No Ethanol group as evidenced 
by the increased trials to criterion and errors committed during both simple discrimination and 
reversal learning tasks. This general cognitive dysfunction was not repeated in the 8 Week 
cohort, but there was evidence for increased difficulty with behavioral flexibility in the rmTBI, 
Ethanol group when the number of errors during each trial were measured.  
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There appeared to be an increase in novelty preference for the Drinking group, and 
specifically the rmTBI, Drinking groups. These effects were statistically significant in the 4 and 8 
Week cohorts, and this pattern persisted for the 2 and 6 Week cohorts as well. This increased 
novelty preference in drinking groups is not surprising, but it is interesting that it was intensified 
by TBI. This increase in novelty preference may be indicative of increased novelty seeking that 
can lead to drug and alcohol abuse or other risky behaviors in human populations.   
When taken together, the data from this study do not suggest any major cognitive 
deficits due to repetitive mTBI, but the SSDRL task may have detected some transient deficits in 
non-specific learning and behavioral flexibility. This would parallel the cognitive dysfunction that 
is reported following rmTBI in human populations as the symptoms of confusion and 
disorientation are not typically apparent at all times and often show spontaneous recovery after 
a couple months. Furthermore, it is possible that the moderate doses of ethanol consumed in 
this study were not enough to exacerbate the deficits in behavioral flexibility that have been 
previously observed in ethanol dependent mouse models (Badanich et al., 2011) thus producing 
inconsistent effects of ethanol exposure.   
 While other researchers have been able to produce consistent cognitive deficits, 
important differences between the models or assessments used could be responsible. For 
example, the number of injuries and how the injuries are incurred could lead to differences in 
cognitive outcomes (Mouzon et al., 2018; Prins et al., 2011; Yang et al., 2015). It is also 
important to consider the type of task being measured as the diffuse nature of rmTBI vs local 
TBI would be important in distinguishing specific deficits, so measures of spatial memory may 
not produce the same deficits as a simple discrimination or reversal learning task. Similarly, in 
mouse models, the most noticeable protracted cognitive deficits are not produced at the 
moderate levels of ethanol consumption observed in this study but are more likely to be 
associated with dependence or binge ethanol models (Fulton T Crews et al., 2004). Combined 
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effects of ethanol and TBI on cognitive deficits are not consistently achieved, which impresses 
upon the importance for continued research (S X Teng & Molina, 2014; Sophie X. Teng et al., 
2015).  
 
Conclusions 
The novel nature of research focusing on combined outcomes of TBI and ethanol 
consumption leaves plenty of opportunities for future research to expand the current findings. 
Cognitive and behavioral measures can be sensitive to damage to specific brain regions, and in 
the case of rmTBI, the damage is often non-specific. This means a number of paradigms will 
need to be characterized with this or similar models to better understand the memory concerns, 
confusion, and concentration difficulties often reported following a concussion, especially when 
combined with ethanol consumption during recovery. While using a model allowing voluntary 
consumption of ethanol is useful for translational studies, it may produce too much variability to 
isolate specific deficits while trying to fully characterize the deficits observed after repetitive 
mTBI and ethanol use. Future studies should consider the combined effects of repetitive mTBI 
and acute binge drinking or chronic ethanol dependence on cognitive and behavioral deficits.  
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DISCUSSION 
 
 Experiment 1 of this series characterized ethanol consumption and preference after 
rmTBI or Sham procedures using a mouse model. The study suggested rmTBI could cause a 
temporary decrease in ethanol consumption, but intake values would return to Sham mice 
drinking levels over time. Experiment 2 investigated the gene expression of TNF-α following 
rmTBI and voluntary ethanol consumption. Interestingly, Sham, Drinking mice showed elevated 
TNF-α expression while the rmTBI, Drinking expression was attenuated in comparison. 
Experiment 3 examined the combined effects of rmTBI and voluntary ethanol consumption on 
cognition and behavior. Results indicated a transient impact of rmTBI and ethanol on learning a 
simple discrimination task and on behavioral flexibility, as well as a slight increase in novelty 
preference due to ethanol consumption and rmTBI independently.  
 
Experiment 1: Effects of Repetitive Traumatic Brain Injury on Voluntary Ethanol 
Consumption 
 In the first experiment of the series, mice drank ethanol (g/kg) and produced BECs at 
levels that would be expected with the DID paradigm (Crabbe et al., 2009; Lee et al., 2017; 
Marianno et al., 2017; J. S. Rhodes et al., 2007; Justin S. Rhodes et al., 2005). These results 
provide support for the use of this drinking model to elicit moderate voluntary ethanol 
consumption and high ethanol preference following rmTBI.  The results also indicated a 
decreased ethanol consumption around the 3 and 4 week marks, similar to the spontaneous 
decrease in alcohol drinking observed in human populations following TBI (Ponsford et al., 
2007). However, following this rmTBI-dependent decrease in ethanol consumption, mice 
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returned to previous drinking levels and did not show an increase in ethanol intake or ethanol 
preference due to rmTBI as predicted. While the goal to model excessive drinking following 
injury was not specifically met, this paradigm is still a useful control for future studies as the 
C57BL/6J is a commonly used base for creating specific genetic mutation models. While using 
this model has its advantages, using the C57BL/6J also inherently introduced some confounds 
that could be parsed out with additional studies.  
 The purpose of the DID paradigm is to produce relatively high levels of ethanol 
consumption and the chosen mouse strain, C57BL/6J, is considered a high ethanol preferring 
strain. Together, ethanol consumption (g/kg) and ethanol preference data showed all mice 
displayed an overwhelming preference for ethanol, and this may be indicative of a ceiling effect 
on voluntary ethanol consumption. This is important to note as it suggests that the rmTBI mice 
may indeed be excessively drinking post-injury, yet group differences are unable to be detected 
as the Sham mice are also excessive ethanol drinkers.  
The DID paradigm only allows for short access to ethanol 4 of 7 days in the week to 
ensure the mice ramp up their drinking when ethanol is presented. It may be possible to discern 
more subtle differences due to rmTBI using a lower ethanol preferring rodent strain or a different 
drinking model (e.g. continuous access, operant self-administration, or sucrose vs quinine 
paradigm; for a review, see Leeman et al., 2011. Each of these drinking paradigms would offer 
specific advantages and disadvantages. For example, continuous access models would remove 
the urgency for the mice to drink during a specific window of time, thereby potentially leading to 
differences in total consumption or consumption periods if used with a continuous monitoring 
system. A disadvantage of the continuous access paradigm is the likelihood that the mice may 
drink more overall, but less in a given time point making it difficult to ensure that the mice drink 
to levels that produce physiologically relevant BECs.  The use of an operant self-administration 
paradigm would specifically be useful if interested in how much effort a mouse would put forth in 
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order to drink which is important to assess motivational and reinforcing properties of ethanol. 
Because one of the proposed explanations of the increased ethanol consumption observed in 
portions of the clinical populations is related to problems with disinhibition, this paradigm could 
be useful to investigate ethanol consumption with progressive schedules. However, the operant 
paradigm requires significant training and typically makes it more difficult examine ethanol 
consumption following injury in a naïve model as some of the training would need to occur prior 
to or during the rmTBI portion of the experiment. Finally, a paradigm adding sucrose or quinine 
(to make the solution bitter) would be useful to compare and contrast motivational and aversive 
factors related to voluntary consumption patterns. These altered ethanol solutions could be 
used with any of the described drinking paradigms to further understand reported consumption 
and preference data.  
 An additional limitation of the study stems from the genetically homogenous nature of 
the C57BL/6J mouse strain. Because these mice exhibit minimal natural genetic variation, they 
are limited in the reproduction of effects observed in clinical populations that are likely at least 
partially due to genetic factors. Specifically, while millions of individuals struggle with alcohol 
abuse, only approximately 20% of TBI patients exhibit excessive drinking without a previous 
history of alcohol use disorder (Bombardier et al., 2003; Dikmen et al., 1995; Horner et al., 
2005). This implies that there may be specific mechanisms such as genetic factors that increase 
vulnerability to excessive drinking post-injury in populations not previously engaged in 
problematic drinking behaviors. This mouse model is not ideal to specifically examine the 
possibility of genetic mechanism as the C57BL/6J mouse strain may lack the genetic 
characteristics necessary to model the increased drinking after TBI. However, this strain is ideal 
for modifying specific genes through knock-in, knock-out, and transgenic mutations to 
investigate genetic targets that may be responsible for this behavior.  
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The current mouse model represents a good control for future studies to examine 
specific factors related to changes in voluntary ethanol consumption following rmTBI. Changes 
to the drinking paradigm or the mouse model may help elucidate specific effects related to 
motivational factors or genetic mechanisms. Additionally, social or psychological factors may be 
responsible for the increased drinking post-injury, so future studies should consider the impact 
of stress (e.g. acute, chronic, and traumatic) and social factors like isolation on changes in 
drinking after TBI. These possible mediating factors could be explored with the current model or 
following modifications to the drinking paradigm or mouse model.    
  
Experiment 2: Effect of Repetitive Mild Traumatic Brain Injury and Voluntary Drinking on 
Neuronal Cytokines 
 In the second experiment, it was expected that the combination of rmTBI and ethanol 
consumption would together compound the independent increase in TNF-α expression 
observed in ethanol consumption and TBI models. However, TNF-α expression was only 
notably elevated in the Sham, Drinking group presumably due to ethanol intake. Conversely, 
TNF-α expression was attenuated in the rmTBI, Drinking group relative to the Sham, Drinking 
group. These results suggest a more complex relationship between ethanol consumption and 
rmTBI mechanisms of inflammation.  
 It should be noted that the Sham and rmTBI procedures both involved exposure to 2-4% 
isoflurane to anesthetize the mice prior to the mTBI or to serve as the Sham procedure. Studies 
using mouse models to investigate clinically relevant durations of isoflurane of approximately 
2hrs (1.4%) did find elevated levels of TNF-α expression due to this prolonged exposure, but 
the authors mention the considerably shorter exposure of 5-10s prior to euthanasia did not elicit 
the same TNF-α response (Wu et al., 2012). The mice in this study were exposed for a few 
minutes during each of the 4 rmTBI or Sham procedures, and prior to euthanasia, so while it is 
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possible that the reoccurring exposure to isoflurane contributed to the elevated TNF-α 
expression observed in this study, it is probably not a major contributing factor to the observed 
changes in TNF-α expression.  
Understanding the possible explanations for the attenuated TNF-α expression in the 
rmTBI groups relative to the Sham groups for 2, 4, and 6 Week cohorts require a deeper 
consideration for the complicated cytokine cascade resulting from neuronal insult. The 
recruitment of cytokines can occur through high-mobility group protein box 1 (HMGB1) mediated 
effects on the family of toll-like receptors (TLR) or the receptor for advanced glycation end 
products (RAGE) pathways, each with unique intracellular mechanisms that lead to nuclear 
factor kappa B (NFκB)-dependent altered gene expression of cytokines (Crews, F. T., Sarkar, 
D. K., Qin, L., Zou, J., Boyadjieva, N., & Vetreno, 2015). In acute doses, ethanol has been 
reported to suppress some of the TLRs and thereby attenuate pro-inflammatory cytokines 
including TNF-α (Goodman et al., 2013; Pruett et al., 2004). Conversely, chronic ethanol 
exposure is most commonly associated with increases in pro-inflammatory cytokines (Fulton T. 
Crews, Qin, Sheedy, Vetreno, & Zou, 2013; Qin et al., 2008; Zou & Crews, 2014). To further 
complicate this response to neural insult via ethanol or injury, the recruitment of cytokines can 
independently occur at neurons, microglia, and astrocytes and may be mediated by different 
factors (Crews, F. T., Sarkar, D. K., Qin, L., Zou, J., Boyadjieva, N., & Vetreno, 2015).  
Studies showing chronic ethanol consumption increased pro-inflammatory cytokines are 
in direct contrast to the attenuation of TNF-α expression observed in the rmTBI, Drinking mice. 
Many of these studies including the current study focus on the pro-inflammatory cytokines like 
TNF-α and IL1-β as researchers are interested in the mechanisms that mediate neuronal 
damage associated with ethanol exposure, however, other anti-inflammatory cytokines may play 
important roles especially in more complicated paradigms of neuronal insult. The first step to 
understanding the observed results would be to confirm ethanol consumption as the mediating 
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factor of the attenuated TNF-α expression in the current study by including rmTBI and Sham, 
Non-Drinking groups for comparison. Additional targets such as the anti-inflammatory cytokine 
IL-10, and other inhibitors of NF-κB could be assessed as well (Qin et al., 2008). It is possible 
that the elevated expression of IL-10 and IL-6 following TBI could continue to be neuroprotective 
against ethanol-induced upregulation of TNF-α and other pro-inflammatory cytokines when 
drinking is initiated following injury (Ziebell & Morganti-Kossmann, 2010).  
 While the 2, 4, and 6 Week cohorts all showed similar patterns of elevated TNF-α 
expression in the Sham, Drinking groups, the 8 Week cohort showed a return to control levels of 
TNF-α expression for rmTBI and Sham, Drinking groups. After 8 Weeks of drinking it is possible 
diminished TNF-α expression could be due to a form of tolerance to prolonged TNF-α elevation 
(Fraker, Stovroff, & Merino, 1988; Huber, Bikker, Welz, Christmann, & Brand, 2017). Recent 
work has indicated possible mechanisms for TNF-α tolerance that could be explored in future 
studies (Gunther et al., 2014).  
 The limitations of the current study include the solitary examination of TNF-α gene 
expression and lack of non-drinking groups for comparison. Future studies should consider 
exploring multiple cytokines simultaneously and provide additional groups for comparison, but 
should also consider histological measures of microglia or astrocyte reactivity, investigation of 
receptor density for the target cytokines, and observation of upstream targets such as HMGB1, 
TRL, and RAGE. This additional information would provide a better understanding of the 
neuronal response to combined insults of rmTBI and ethanol consumption as a whole.  
 
Experiment 3: Combined Effects of Repetitive Mild Traumatic Brain Injury and Chronic 
Alcohol Consumption on Cognition and Behavior  
 The voluntary ethanol consumption data repeated in this experiment provided overall a 
good replication of the data obtained in Experiment 1. Key differences included increased 
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consumption in Experiment 1, 6 and 8 Week cohorts relative to most cohorts in Experiment 1 
and Experiment 3 and increased ethanol preference specific to rmTBI in the last weeks of 
Experiment 3, 8 Week cohort compared to the other cohorts in Experiment 3. It is not clear how 
to account for the elevated ethanol intake in Experiment 1, 6 and 8 Week cohorts relative to 
most other groups in both Experiment 1 and Experiment 3, but it might be related to some of the 
variability and inconsistencies in other measures including BEC and related outcomes.  The 
typical average daily consumption in most cohorts ranges from 1.5 – 2.5g/kg whereas the 6 and 
8 Week cohorts are consistently closer to 3g/kg. The rmTBI specific increase in ethanol 
preference during the final weeks of Experiment 3, 8 Week cohort is less clear and possibly a 
matter of individual differences as this pattern was not evident in the first experiment but still 
within a similar range as the initial 8 Week cohort.  
 While the repetition of the voluntary ethanol consumption experiment was inherently 
useful to provide support for the initial results, the primary focus of Experiment 3 was to assess 
the cognitive and behavioral outcomes following the combination of rmTBI and ethanol 
consumption. As a whole, the SSDRL task provided a valid measure of behavioral flexibility by 
demonstrating a general capacity for learning a simple discrimination task and increased 
difficulty with reversal learning. The group dependent effects were interesting, but not entirely 
clear as the cognitive deficits observed were often transient between cohorts. For example, the 
observation of cognitive deficits in the 2 Week cohort suggested the rmTBI, Drinking group 
experienced general difficulty learning the simple discrimination task in addition to difficulties 
with reversal learning, whereas the rmTBI, No Drinking group displayed a strong deficit in 
behavioral flexibility only. This is in contrast to the lack of group differences in the 4 Week 
cohort, and contrary to the observation in the 6 Week cohort showing general learning deficits in 
the rmTBI, No Drinking group and behavioral flexibility specific deficits in the rmTBI, Drinking 
group. In the 8 Week cohort, deficits in cognition could only be observed with the more sensitive 
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measure of errors during each task, and suggest the more resistant rmTBI dependent effect is 
in the rmTBI, Drinking group.  
The most obvious explanation for the inconsistent rmTBI dependent deficits is that 
concussive deficits are often transient in nature, and therefore are only sometimes made worse 
with the addition of ethanol consumption. However, this explanation cannot be empirically 
supported in this study as measures of neural damage are not available to correlate with the 
changes in cognition. The diffuse nature of mTBI makes a physical assessment of the injury 
more difficult, but measures of astrocyte reactivity or neuronal degeneration would be good 
measures to consider. Future studies should also consider using DTI imaging to measure the 
integrity of white matter tracts that are important to executive functions like reversal learning and 
working memory integral to success in the SSDRL task used in this study.  
 The behavioral data focusing on novelty preference measured in the novel object 
recognition task alluded to potentially interesting increases in novelty seeking due to ethanol 
consumption and rmTBI together. The objects used in this study were plastic, 3D shapes and 
may not have been different enough to elicit a greater response to novelty. Future studies 
should consider altering shape more dramatically, as well as, altering the material of the object 
to ensure a strong distinction between objects. Since a 30min inter-trial interval was used in the 
novel object portion of the open field series, deficits in short-term memory were not apparent. 
Future studies should consider 24hr inter-trial intervals to assess long-term memory as well.  
 The mild nature of the TBIs and the moderate levels of ethanol consumed in this 
paradigm lend to a translational model of rmTBI and ethanol intake, but also lead to increased 
variability in cognitive and behavioral changes. Additional work should consider the 
administration of ethanol at low, moderate, and high doses following rmTBI to better control 
ethanol mediated effects. Lastly, this study also only addresses cognition and behavior post-
injury in ethanol naïve mice, and in humans, it is more likely that alcohol exposure starts prior to 
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injury. Future studies should also consider pre-treatment of ethanol and possibly even the use 
of ethanol-dependent mice with the rmTBI paradigm to assess changes in cognition and 
behavior.  
Conclusion 
 The overall impact of this series of studies primarily resides in the novel contribution to 
the literature regarding rmTBI and voluntary ethanol consumption. While Experiment 1 was not 
able to model the excessive drinking observed in a portion of the clinical population following 
TBI, it provides a foundation for future investigations to uncover the mechanism underlying this 
problematic behavior. Experiment 2 examined TNF-α expression, a possible shared mechanism 
of neuronal damage of both rmTBI and ethanol consumption, and uncovered a curious 
attenuation of TNF-α expression when rmTBI was followed by voluntary ethanol consumption 
despite observing the expected increase in TNF-α expression due to ethanol consumption in 
Sham mice. The results of Experiment 3 investigating the combined effects of rmTBI and 
ethanol consumption demonstrated transient cognitive deficits and behavioral changes in 
novelty preference. The nature of mild TBI and moderate ethanol consumption make 
investigation of the combined and independent outcomes more difficult, but the widespread 
impact of both emphasize the need for translational models such as the one employed in these 
studies.    
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